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ABSTRACT 
 
NMDA Receptor Hypofunction in the Developing Prefrontal Cortex in Two Animal 
Models for Schizophrenia: Expression Profile, Epigenetic Mechanisms, and Physiology 
 
Yelena Gulchina 
Advisor: Wen-Jun Gao, Ph.D. 
 
 Schizophrenia is a highly debilitating illness often diagnosed in late adolescence 
and early adulthood following the emergence of psychotic symptoms. In addition to 
psychosis, negative symptoms and cognitive deficits are characteristic of the disorder, 
and are often evident prior to diagnosis. While positive symptoms are often attenuated 
with antipsychotic treatment, cognitive dysfunctions are unresponsive to therapeutic 
agents and persist throughout the course of the illness. As the best determinant of 
functional outcome, targeting the pathophysiology of cognitive deficits has become a 
priority for government agencies, academic research institutions, and the pharmaceutical 
industry. Among the prominent hypotheses attributed to schizophrenia, cortical 
hypofunction of the glutamate neurotransmitter system is an appealing possibility due to 
the importance of N-methyl-D-aspartate receptors (NMDARs), a type of ionotropic 
receptor, in brain development and cognition. Interestingly, blocking NMDARs during 
juvenile development is sufficient to elicit schizophrenia-like phenotypes in adult 
animals. Further, schizophrenic subjects display significant prefrontal hypofunction 
during performance of cognitive tasks. Compelled by the importance of the NMDAR 
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system in the development and maturation of the prefrontal cortex, this work explores the 
expression profile and functional properties of the NMDAR system during juvenile and 
adolescent development in two animal models for schizophrenia: the neurodevelopmental 
MAM model and the inducible hDISC1 mutant mouse model. We confirm that NMDAR 
hypofunction is a feature of prefrontal development in these two models, albeit by 
changes in expression of divergent subunits. Further, we explore a mechanism by which 
NMDAR expression changes occur in the juvenile prefrontal cortex, implicating aberrant 
epigenetic regulation of the NR2B subunit. These data support the neurodevelopmental 
hypofunction hypothesis and highlight the importance of investigating early prefrontal 
dysfunction to understand the complex pathology observed in the chronic stage of 
schizophrenia.  
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CHAPTER 1: GENERAL INTRODUCTION 
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Schizophrenia 
 
Historical perspective 
 
 A century ago, Emil Kraeplin introduced the term “dementia praecox” to describe 
a common behavioral pattern he observed in his patients in the course of an illness, 
resulting in cognitive and executive dysfunction. Shortly after, Eugen Bleuler coined the 
term “schizophrenia” and constructed the earliest definition of what are now known as 
positive symptoms (Jablensky, 2010). In the 1970s, “positive” and “negative” symptoms 
were used to sub-classify schizophrenia (SCZ) into two mutually exclusive disorders: 
Type I (positive) was characterized by hallucinations and delusions, while Type II 
(negative) was defined by social withdrawal, poverty of speech, and flattened affect 
(Strauss et al., 1974; Crow, 1980). To this day, these symptoms are among those used to 
diagnose SCZ; however, this concept of mutual exclusivity between the two symptom 
domains has evolved into a condition where both symptom types co-occur in patients 
(Crow, 1985). Cases of SCZ can be separated by their familial or sporadic etiology, 
where the former is due to a traceable genetic mutation, and the latter can be due to 
environmental insults, in vivo somatic mutations, or both. This dichotomous etiology 
cannot be distinguished by differential phenotypic characteristics (Gottesman and 
Bertelsen, 1989; Roy and Crowe, 1994), suggesting the downstream effects in both 
circumstances converge on a common neurobiological dysfunction. Further, it has been 
difficult to identify consistent genetic vulnerabilities in SCZ by genome-wide association 
studies (GWASs). In fact, structural and neurochemical abnormalities are among the 
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most consistent features reported from analyses of post-mortem SCZ brains, but these 
variables lack the sensitivity to be classified as diagnostic biomarkers of the disorder 
(Jablensky, 2010). Over time, we have collected many pieces of the puzzle, but continue 
working to identify the role of each.  
 
Economic and psychosocial burden of schizophrenia 
 
SCZ is a severely debilitating mental disorder that persists throughout the lifetime 
of a patient. The economic and psychosocial burden on patients and family caregivers is 
substantial, as productivity is significantly diminished and family members often 
experience mental health disturbances as well (Awad and Voruganti, 2008). The global 
prevalence of SCZ is 1.1% and estimates of the annual cost of the disorder range from 
$63 billion to $180 billion in the United States (Ball et al., 2005). These high costs, 
reflective of direct and non-direct spending, were significantly higher than those of other 
major mental illnesses (Greenberg et al., 2003). The development of improved 
antipsychotics has contributed to reductions in medical expenses (Ball et al., 2005); 
nonetheless, the debilitating nature of SCZ and growing economic burden drives 
continued efforts to identify more efficient treatment strategies. To achieve this goal, 
efforts to understand the functionally-debilitating, physiological underpinnings of this 
disorder are underway.  
 
Symptom categorization 
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The positive symptom domain is the most prominent diagnostic criteria for SCZ 
(Jablensky, 2010; Kahn and Sommer, 2015). These symptoms, commonly referred to as 
psychosis, are comprised of hallucinations, delusions, and thought disorder. The first 
presentation of psychosis is typically during late adolescence or early adulthood and 
pinpoints the age of onset of SCZ (Kahn and Sommer, 2015). Yet cognitive deficits, 
mood abnormalities, and anxiety are common features of the prodrome stage (Cannon et 
al., 2000; Gajwani et al., 2013; Fusar-Poli et al., 2014); therefore, strict delineation of the 
age of onset by one symptom cluster is too limiting.  
 
In addition to psychosis, another set of behavioral abnormalities reported in SCZ 
patients are negative symptoms (Jablensky, 2010), including social withdrawal, poverty 
of speech, and flattened affect (Kirkpatrick et al., 2006). Individuals at high risk of 
converting to SCZ exhibit attenuated negative symptoms even prior to psychosis, 
indicating the developmental mechanisms that contribute to these symptoms may lend 
insight into the etiology of SCZ (Fusar-Poli et al., 2014). To streamline the diagnostic 
criteria, approach to clinical trial design, and therapeutic needs of SCZ patients, 
Kirkpatrick et al. (2006) in conjunction with the National Institute of Mental Health 
(NIMH) hosted a conference among clinicians, scientists, and pharmaceutical agencies to 
establish an industry consensus (Kirkpatrick et al., 2006). Unfortunately, imaging and 
neurochemical analyses of SCZ brains has led to few consistent findings in regards to 
negative symptoms (Galderisi et al., 2015); thus, the neurobiological contributions to this 
symptom cluster are still unclear. 
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Indeed, cognitive and executive dysfunction are among the core features of SCZ, 
as Kraeplin reported a century ago (Jablensky, 2010). Cognitive deficits are the best 
determinant of functional outcome for patients (Bowie and Harvey, 2006) because they 
remain consistent during early onset and chronic stages of the disorder (Hoff et al., 2005). 
Importantly, impairments in cognition are evident prior to psychosis (Cannon and Jones, 
1996; Cornblatt et al., 1999; Rosso et al., 2000; Cannon et al., 2002), indicating 
pathological mechanisms begin during development in the course of SCZ. With estimates 
that as many as 90% or more of patients exhibit these cognitive abnormalities (Green et 
al., 2004), in addition to the pervasiveness of this dysfunction (Hoff et al., 2005), and 
limited efficacy of FDA-approved antipsychotics (Harvey and Keefe, 2001), this final 
symptom cluster has evolved into the primary focus of current research efforts. This 
culminated in the creation of MATRICS (Measurement and Treatment Research to 
Improve Cognition in Schizophrenia) with a similar goal to that set forth by Kirkpatrick 
et al. (2006) and NIMH (Green et al., 2004). An early meta-analysis of 7420 SCZ 
patients and 5865 control subjects revealed several neurocognitive constructs 
significantly impaired in SCZ, including verbal memory, attention, cognitive flexibility, 
working memory, processing speed, and intelligence quotient (IQ) (Heinrichs and 
Zakzanis, 1998). The MATRICS committee conducted a systematic assessment of the 
literature with the goal to identify the most replicated cognitive domains that would yield 
measurable outcomes during dysfunction and recovery in clinical trials. Green et al. 
(2004) expanded upon Heinrichs and Zakzanis (1998) findings to include social 
cognition, visual learning and memory, and reasoning and problem solving (commonly 
referred to as executive functioning, incorporating cognitive flexibility) (Green et al., 
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2004). Thus, the seven domains of cognitive deficits in SCZ were outlined to update 
diagnostic criteria, and revise the guidelines for identifying and assessing therapeutic 
agents in clinical trials. In order to understand the importance of these domains in 
disease, one must appreciate their importance in normal cognitive and cellular processes.  
 
Importance of the prefrontal cortex in cognitive control 
 
In order to act appropriately in response to environmental demands, humans can 
organize their thoughts and behaviors into functional responses by integrating 
information from the current context with past experiences. The prefrontal cortex (PFC) 
is essential to this integrative process. Of particular importance for daily functioning, 
working memory is the ability to receive a stimulus, hold that information temporarily in 
mind, and subsequently respond in a goal-directed manner (Baddeley, 2012). Organisms 
are exposed to chaotic surroundings, incessantly bombarded with external stimuli; a 
system must be adept in filtering out irrelevant details and focus on pertinent information 
so that an appropriate response can be provoked. Working memory acts as the hub in 
processes necessary for higher cognitive and executive function, including thinking, 
planning, and comprehension (Baddeley, 1992; Goldman-Rakic, 1996). This form of 
short-term memory is provisionally active and serves as a middleman between the 
dynamic environment and long-term consolidation. Continual presentation of a relevant 
stimulus can lead to more permanent retention of that memory, while previously 
important information can be retrieved and returned to working memory manipulations to 
update mental schemas (D'Esposito et al., 1995; Goldman-Rakic, 1995). Working 
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memory is a vital neurological process that allows organisms to appropriately manage the 
continuously changing world in a practical manner. The ability to read a story or navigate 
to a new destination are typical examples of working memory application. Engaging in 
such activities requires an individual to rapidly recall stored information from prior 
experiences and at the same time, focus on the influx of new information in order to 
understand and accomplish the current task. Overall, working memory can be considered 
a cerebral sieve in which the PFC first sorts incoming stimuli into essential and 
disposable information, recruiting and coordinating with other brain regions to manage 
the information. Working memory is thus a delicate process steering us through the daily 
chaos of modern life.  
 
The PFC is a molecularly, neuroanatomically, and functionally distinct brain 
region that governs higher cognitive functions, including working memory, upon which 
affective recall, attention, and behavioral inhibition depend (Goldman-Rakic, 1996). As 
an important gatekeeper of incoming stimuli, it exerts top-down control by promoting 
behaviors that will benefit the individual in a context-specific manner. Increased 
exposure to unfamiliar environments will be stored and later retrieved when a goal-
directed behavior is necessary, contributing to decision-making. Seeing that several 
executive processes involve PFC functioning, this area is thus crucial for guiding 
efficient and appropriate behavior. From this point, we will focus on describing working 
memory processes given their foundational role in higher-order cognition.  
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A growing body of literature has demonstrated the PFC’s paramount role in 
working memory (Goldman-Rakic, 1995) and SCZ (Goldman-Rakic and Selemon, 1997). 
Lesion studies have continually confirmed that damage to the PFC results in working 
memory deficits, as assessed by performance on spatial delayed-response tasks (Goldman 
et al., 1971; Passingham, 1975; Mishkin and Manning, 1978; Goldman-Rakic, 1996; 
Buckley et al., 2009). During cognitive performance tasks, SCZ patients consistently 
demonstrate reduced activation of the dorsolateral PFC (dlPFC) (MacDonald et al., 2005; 
Lesh et al., 2011; Van Snellenberg et al., 2016). Mechanistically, electrophysiological 
recordings have revealed preferential sustained activity in the PFC during engagement in 
a delayed-response working memory task. Information perceived as important is retained 
transiently in mind, which requires continual robust firing in order for the PFC to 
properly execute top-down control (Arnsten et al., 2010). Prefrontal neuronal firing 
increases following presentation of a salient cue, continues throughout a delay period in 
which stimuli are completely absent, returning to baseline once a response has been 
generated (
11 
 
Figure 1). This specialized activation in prefrontal cortical neurons reflects an ‘on-line’ 
sustained activity, which fosters mnemonic encoding (Fuster and Alexander, 1971; 
Goldman-Rakic, 1996). This unique firing property in a subpopulation of PFC neurons, 
referred to as Delay cells, is postulated to be the molecular underpinning of working 
memory. The local PFC circuitry is specialized for such sustained activity, providing a 
neural correlate for working memory function (Goldman-Rakic, 1995).  
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Figure 1 
 
Delay cell firing supports working memory function. The schematic of the oculomotor 
delayed-response task illustrates the cellular mechanism of visual working memory 
necessary for the proper behavioral response, a saccade to a previously cued location. 
During the cue, Delay cell firing tuned for a specific location increases and is maintained 
throughout the delay period. Once the behavioral response is generated, Delay cell firing 
is diminished as it is no longer necessary. Figure reprinted from Monaco et al. (2015). 
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NMDARs in cognition, development, and schizophrenia 
 
Subunit composition bestows unique functional properties upon NMDARs 
 
N-methyl-D-aspartate receptors (NMDARs) are heterotetrameric complexes 
composed of a mandatory homodimer of NR1, and homodimers of either NR2 (NR2A-D) 
or NR3 (NR3A-B) subunits, or heterodimers of NR2 and NR3 subunits (Ogden and 
Traynelis, 2011). The NR1 subunit is vital for targeting NMDARs to discrete regions of 
the cell surface as well as membrane insertion; therefore, receptors lacking this subunit 
are not functional (Cull-Candy and Leszkiewicz, 2004). The NR2 and NR3 subtypes, 
however, afford functional heterogeneity to the NMDAR complex. These subunits dictate 
such functional characteristics as open channel time, calcium permeability, decay time, 
and sensitivity to Mg2+ block as well as pharmacological agents (Paoletti et al., 2013). Of 
particular interest, NR2A and NR2B are predominantly expressed in the postnatal brain 
with both subunits integral for synaptic plasticity and maturation mechanisms (Monyer et 
al., 1994; Sheng et al., 1994). 
 
Although NMDARs are critical, not all subunits are created equal when it comes 
to working memory and cognitive function. NR2A- and NR2B-selective antagonists were 
useful in beginning to parse out the contribution of these individual subunits to cognitive 
processes. Long-term potentiation (LTP) was attenuated following NR2A antagonism in 
ex vivo slices, but completely blocked by an NR2B antagonist; thus, demonstrating that 
both NR2A and NR2B contribute to prefrontal synaptic plasticity, but NR2B plays a 
14 
 
more dominant role (Cui et al., 2011; Plattner et al., 2014). The importance of NR2B 
subunits in learning and memory processes was first brought to light by transgenic 
manipulations. As determined by studies utilizing NR2B overexpression methods, this 
subunit heavily contributes to memory function. Forebrain-restricted NR2B 
overexpression (Tang et al., 1999; Cui et al., 2011) results in extended NMDAR channel 
opening in conjunction with enhanced NMDAR activation, thereby facilitating learning 
and memory across an entire cognitive spectrum and enabling adult mice to exhibit 
“smarter” performance in cognitive tasks compared to their wild-type counterparts (Tang 
et al., 1999; Cui et al., 2011). Moreover, overexpression of NR2B also altered synaptic 
plasticity, with selective enhancement in LTP while long-term depression (LTD), basal 
synaptic transmission, and paired-pulse depression remained comparable between 
transgenic and wild-type animals (Tang et al., 1999; Cui et al., 2011). These data 
demonstrate that NR2B plays an important role across a gamut of memory functions and 
that expression of this subunit strongly impacts intellectual capabilities. Specifically, 
overexpression of NR2B in the forebrain not only affected long-term synaptic plasticity 
at a cellular level, but also translated into a behavioral change (Tang et al., 1999; Cui et 
al., 2011). Remarkably, altering the expression levels of this one protein can dramatically 
impact PFC-dependent working memory function. Thus, NMDARs are an important 
molecular substrate for cognitive processes, with the NR2B subunit particularly 
implicated in PFC-dependent cognition (Cao et al., 2007; Wang and Gao, 2009; Cui et 
al., 2011; Wang et al., 2013; Lett et al., 2014). Conceivably, alteration of NR2B levels in 
disorders presenting with cognitive deficits, such as SCZ, may contribute significantly to 
these functional impairments (Snyder and Gao, 2013; Plattner et al., 2014). 
15 
 
 
Computational modeling and work in the primate dlPFC has been integral in 
identifying the specific nature of NR2B’s role in working memory. It has been proposed 
that NR2B grants the physiological requirements necessary for working memory function 
because of its slower decay time compared to NR2A. NR2B-containing receptors 
(NR2B-NMDARs) can conduct a large number of Ca2+ and Na2+ ions during their 
intrinsically longer open channel state (Wang, 1999; 2001), thereby prolonging 
depolarization events (Cull-Candy et al., 2001; Wang, 2001) and synaptic summation 
(Wang et al., 2008) essential for working memory function. More efficient temporal 
summation patterns help bring the neuron closer to the spike-firing threshold of the cell 
(Kumar and Huguenard, 2003), which in turn promotes sustained activity. The delay 
period between perception of a stimulus and the elicited response employs neurons to 
stay online, actively engaged. The NR2B subunit affects NMDAR channel kinetics so 
that the persistent firing pattern necessary for PFC-dependent cognitive functions, such as 
working memory and cognitive flexibility, can thus be maintained (Goldman-Rakic, 
1995; Wang, 1999; Wang et al., 2013).  
 
This long-held hypothesis was supported by a recent elegant study, in which 
Wang et al. (2013) provided the first direct evidence that NMDAR functioning underlies 
persistent firing specifically in primate dlPFC Delay cells (Wang et al., 2013). 
Generalized blockade of NMDAR activity depressed Delay cell firing and working 
memory function. Importantly, selectively blocking NR2B activity significantly 
suppressed Delay cell firing, demonstrating a direct action of NR2B in the working 
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memory task. In contrast, blockade of AMPARs (-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors) showed a lag effect in which activity was decreased 
later in the Delay cell firing period, not immediately. These data suggest that AMPAR 
activity may serve to support depolarization events in Delay cells, whereas NMDARs, 
especially NR2B subunits, are required for the moment-to-moment firing necessary for 
working memory function (Wang et al., 2013). Therefore, we can appreciate this vital 
receptor is at the forefront of a highly complex network that encodes working memory 
and facilitates higher-order cognitive processes. 
 
Persistent expression of NR2B is distinct to PFC development 
 
NMDAR subunit expression is regionally- and developmentally-restricted, 
thereby contributing to the brain’s complexity by imposing unique physiological and 
functional properties within individual brain regions (Cull-Candy and Leszkiewicz, 
2004). A subunit switch from mostly NR2B- to NR2A-containing NMDARs occurs at a 
time coincident with circuit refinement necessary for maturation of synapses and learning 
capabilities (Dumas, 2005). Physiological changes indicative of this maturational process 
include reduced decay time constant, enhanced temporal summation properties, and 
reduced sensitivity of the NMDAR complex to NR2B-specific antagonists, such as 
ifenprodil and Ro25-6981. The PFC is unique relative to other brain regions because an 
NR2B-to-NR2A subunit switch that occurs in several other neuroanatomical regions 
(Dumas, 2005) appears to be absent in the PFC local circuitry (Wang et al., 2008). Over 
the course of neurodevelopment, NR2B levels do not decline, but remain persistently 
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high in the adult rat PFC (Figure 2) (Wang et al., 2008). Lack of an NR2B subunit switch 
serves to fit PFC function for working memory by preserving the physiological properties 
necessary for sustained activity. During the execution of working memory function, 
stimulation of glutamatergic pyramidal neurons results in persistent activity, and the 
temporal summation of these inputs is facilitated by the presence of NR2B subunits 
(Flores-Barrera et al., 2014). Seeing that the PFC retains high expression of NR2B, this 
brain region is ideal for supporting mnemonic encoding.  
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Figure 2 
 
PFC pyramidal neurons do not exhibit a subunit switch from primarily NR2B- to 
NR2A-NMDARs as do other cognitive centers. (A) Decay of NMDAR-mediated 
currents is not significantly changed in pyramidal neurons throughout postnatal 
development of the PFC, as would be expected following the switch to predominantly 
NR2A-NMDARs. (B) A significant component of NMDAR-mediated current is blocked 
by the NR2B-selective antagonist ifenprodil, confirming a large NR2B-component in 
adult PFC. Figure modified and reprinted from Monaco et al. (2015). 
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The NR2B-to-NR2A subunit switch does not dictate functional maturation of the PFC 
 
The NR2A/NR2B ratio is a critical regulator of synaptic plasticity function in 
addition to its role in cognition. Many brain regions, including the hippocampus and 
primary sensory cortices, undergo this subunit switch from primarily NR2B- to NR2A-
NMDARs, which eventually results in a higher ratio of NR2A/NR2B (Williams et al., 
1993; Sheng et al., 1994; Gonzalez-Burgos et al., 2008; Wang et al., 2008; Paoletti et al., 
2013). The maturation of these regions through the increased role of NR2A allow rapid 
responses to incoming environmental stimuli. In mature primary visual cortex, the high 
NR2A/NR2B ratio endows the neural circuitry with rapid temporal summation properties 
and receptive field maturation (Philpot et al., 2001; Cho et al., 2009). Similarly, in the 
mature hippocampus where the NR2A/NR2B ratio is high, LTP is heavily mediated by 
NR2A-containing receptors, and can be significantly diminished in the presence of 
NR2A-specific, but not NR2B-specific, antagonists (Zhao et al., 2005), although this 
issue remains controversial (Yashiro and Philpot, 2008). Thus, in sensory cortices, 
hippocampus, and many other cortical regions, NR2A-NMDARs dictate cognitive 
functions associated with long-term synaptic plasticity in adulthood.  
 
In the PFC, however, the NR2A/NR2B ratio is stable throughout development, 
which is distinctly different from these aforementioned brain areas with associative 
learning capabilities (Dumas, 2005; Wang et al., 2008). In the adult rat PFC, a significant 
NR2B-component is evident (Figure 2B, (Wang et al., 2008). Indeed, the maintenance of 
NR2B-NMDARs aids synaptic and functional maturation of the PFC. In late adolescence 
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and early adulthood, but not earlier developmental time points, LTP can be induced in the 
PFC upon stimulation of the ventral hippocampus. This developmental stage corresponds 
to a time of peak contribution from NR2B-NMDARs in the PFC, indicating this 
molecular component is required for circuit maturation between regions. Blockade of the 
NR2B subunit or NMDARs in the PFC at this later developmental stage abolishes LTP 
(Flores-Barrera et al., 2014). These data indicate that the NR2B subunit intimately 
regulates circuit refinement and functional maturation of the PFC, which is necessary for 
normal functioning of working memory and higher-order cognition.  
 
Working memory is a dynamic and transient process compared to long-term 
memory consolidation and storage; thus, it is not surprising that the molecular 
mechanisms governing these processes are fundamentally different (Taylor et al., 1999; 
Arnsten and Jin, 2014). Differing from the PFC, other cortical areas experience a decline 
in NR2B protein levels during development, and at adulthood reach a level of expression 
that will be maintained until aging (Dumas, 2005). NR2A protein levels rise in parallel to 
this process such that mostly post-synaptic NR2A-NMDARs govern synaptic physiology. 
However, the molecular mechanisms that drive this switch are still poorly characterized. 
In sensory cortices and hippocampus, this switch is strongly dependent on experience and 
neuronal activity (Yashiro and Philpot, 2008). However, experience- and activity-
dependent plasticity do not appear to guide prefrontal development in a similar fashion as 
the PFC lacks direct thalamocortical innervation from the sensory thalamus with the 
exception of the mediodorsal nucleus of the thalamus (Giguere and Goldman-Rakic, 
1988; Conde et al., 1990; Ray and Price, 1992; Ferguson and Gao, 2014). Instead, 
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synaptic pruning and infiltration of neuromodulator systems contributes to functional 
maturation of the PFC. The dopaminergic system is one critical element of this process 
on which we will focus due to its relevance to SCZ pathology.  
 
Dopaminergic signaling modulates working memory and functional maturation of the 
PFC 
 
Thus far, we have described that neuronal activity and working memory function 
in the PFC are intimately linked to the NMDAR; however, this receptor cannot act in 
solitude. NMDARs are at the core of a dynamic network of receptor complexes and 
signaling cascades, which regulate neuronal activity and ultimately, working memory and 
higher-order cognitive capabilities (Paoletti et al., 2013). The dopamine system is one 
such critical regulator of NMDAR-induced activity, poised for this role by its close 
proximity to NMDAR complexes within dendritic spines (Arnsten and Jin, 2014). 
Dopamine D1 receptor (D1R) stimulation exerts modulatory effects on working memory 
performance in an inverted-U dose response manner (Arnsten et al., 1994; Vijayraghavan 
et al., 2007); moderate levels of stimulation enhance the signal-to-noise ratio by 
sustaining preferred direction firing while simultaneously dampening non-preferred 
direction firing. Thus, the dopamine system can sharpen the tuning of PFC microcircuitry 
to promote appropriate cognition and goal-directed behaviors. In contrast, higher levels 
of dopamine receptor activation induce an overall suppression of delay-related firing in 
both preferred and non-preferred responses (Williams and Goldman-Rakic, 1995; 
Vijayraghavan et al., 2007), creating a discord in communication that will impair 
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working memory function. Moreover, refinement of the NMDAR relies on the dopamine 
pathway; co-activation of NMDA and dopamine receptors facilitates the functional 
maturation of the PFC (Flores-Barrera et al., 2014). Thus, the development of prefrontal 
maturation is strongly dependent upon the dopamine system in addition to NMDARs. 
Dysfunction of either or both of these neurotransmitters can have devastating effects on 
cognition, motor function, and perception; thus, dopamine signaling is another integral 
player in both normal cognitive performance and in SCZ pathology (Seamans and Yang, 
2004). 
 
The first hypothesis of SCZ: cortical hyperdopaminergia 
 
The first suggestion of dopamine contributing to SCZ was evidenced by the 
psychosis-like behaviors exhibited by consumers of amphetamine, a dopamine reuptake 
inhibitor (Matthysse, 1974). Cortical hyperdopaminergia was one of the first hypotheses 
regarding the neurochemical abnormalities of SCZ (Perez-Costas et al., 2010). The 
successful abatement of positive symptoms with neuroleptic agents, later shown to 
preferentially inhibit dopamine D2Rs (Ito et al., 2012), lent additional credence to this 
hypothesis (Konradi and Heckers, 2003; Brisch et al., 2014). Now known as typical 
antipsychotics, these were successful in treating positive symptoms; however, negative 
symptoms and cognitive deficits were often untreated or even worsened by these drugs. 
Their strong extrapyramidal effects on motor function (Lewis and Lieberman, 2000) left 
many chronically-treated patients with irreversible dyskinesia and other parkinsonian-like 
dysfunctions. The evolution of second-generation atypical antipsychotics provided some 
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relief from these harsh side effects without compromising the efficacy in treating 
psychosis. This new generation of treatments only partially block D2Rs and exert 
additional modulation on the serotonergic system (Meltzer and Massey, 2011). 
Unfortunately, neither typical nor atypical antipsychotics demonstrate clear 
improvements in cognition or daily function (Harvey and Keefe, 2001). Therefore, while 
the dopaminergic system clearly contributes to SCZ pathology, it alone cannot account 
for the pervasive nature of mood alterations and cognitive dysfunctions (de Bartolomeis 
et al., 2013; Laruelle, 2014), thus implicating other neurochemical systems in the etiology 
of the disorder. 
 
The glutamate hypothesis of SCZ: NMDAR hypofunction in the PFC 
 
Similar to dopamine, drug-induced exacerbation of positive and negative 
symptoms, and cognitive deficits implicated the glutamate system in SCZ. Phencyclidine 
(PCP) and ketamine, non-competitive NMDAR antagonists (Anis et al., 1983), are able to 
evoke psychosis in stably-treated patients (Lahti et al., 1995) and normal subjects 
(Krystal et al., 1994; Malhotra et al., 1996; Jentsch and Roth, 1999). Importantly, and 
unlike dopamine receptor antagonists, these drugs can also elicit cognitive dysfunction 
(Krystal et al., 1994; Newcomer et al., 1999) and negative symptoms of SCZ (Malhotra et 
al., 1996). A surge in development of animal models for SCZ using pharmacological 
blockade of NMDARs, particularly PCP, revealed a number of common behavioral 
phenotypes between animals and humans. Animal models are utilized not only to explore 
the neurobiology of SCZ-relevant behaviors, but also to identify and test the therapeutic 
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potential of pharmacological agents to alleviate these dysfunctions. However, this 
approach must be carefully considered, as many positive outcomes in preclinical models 
rarely demonstrate translational efficacy when tested in clinical trials.  
 
Pharmacologically-induced NMDAR hypofunction mimics cognitive deficits of SCZ 
 
Pharmacological blockade of NMDAR activity has been shown to diminish 
working memory and cognitive functions across several mammalian species, reinforcing 
the ubiquitous impact of these glutamate receptors. Working memory performance in 
conscious monkeys was impaired following chronic administration of the NMDAR 
antagonist MK-801 (Tsukada et al., 2005). Further, rats treated with ketamine or MK-801 
show disrupted working memory performance in a delay-independent manner, (Aultman 
and Moghaddam, 2001), a phenotype reliably produced in human subjects (Krystal et al., 
1994; Malhotra et al., 1996; Newcomer et al., 1999; Hetem et al., 2000; Parwani et al., 
2005). The most common pharmacologically-induced preclinical model for SCZ uses 
PCP, which can more reliably reproduce deficits in the cognitive domains outlined by 
MATRICS than MK-801(Jentsch and Roth, 1999; Kirkpatrick et al., 2006). Adult PCP-
treated animals demonstrate deficits in prefrontal-dependent cognitive domains such as 
working memory (Seillier and Giuffrida, 2009), reversal learning (Jentsch and Taylor, 
2001), and attention (Egerton et al., 2005), among other social and sensorimotor 
constructs observed in SCZ patients (Jones et al., 2011). Interestingly, some of these 
behaviors can be attenuated by treatment with typical or atypical antipsychotics (Jentsch 
and Taylor, 2001). Addition of adjuvant molecules that are proposed to boost NMDAR 
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function have also shown positive results, although complicated by this mixed 
pharmacological approach. This is somewhat in conflict with evidence that neither typical 
nor atypical antipsychotics cause substantial amelioration of cognitive deficits (Harvey 
and Keefe, 2001), and have been interpreted as reinforcing the construct validity of these 
pharmacological models. In addition, PCP-treated animals exhibit neurobiological 
alterations commonly reported from post-mortem human analyses, such as reduced 
hippocampal volume, diminished dendritic complexity, and prefrontal hypometabolism. 
Therefore, these models lend valuable but limited insights into the structural and 
cognitive consequences of acute or chronic NMDAR blockade; however, this approach 
disregards the potential genetic and neurodevelopmental contributions to SCZ pathology. 
 
Genetic mutations in SCZ patients 
 
A unique gene encodes each subunit of the NMDAR. Polymorphisms in the genes 
that encode NR1, NR2A, and NR2B, in particular, are segregated with SCZ diagnosis. 
Chronically-ill SCZ patients who are carriers of a single nucleotide polymorphism (SNP) 
in Grin2b, the gene encoding NR2B, show a significant reduction in reasoning 
performance compared to controls (Weickert et al., 2013). In addition, this SNP results in 
a greater reduction of NR1 protein and mRNA in the dlPFC compared to carrier control 
subjects, which may lead to overall loss of NMDAR insertion and therefore function. 
Analysis of NMDAR mRNA levels in post-mortem SCZ tissue has resulted in conflicting 
findings, however, and studies report increases, decreases, or no change in transcript 
levels (Coyle, 2012). This inconsistency hinders our ability to identify whether the 
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pathophysiological mechanisms underlying SCZ are a direct result of diminished 
NMDAR subunit proteins (Weickert et al., 2013). Nevertheless, mutations in Grin2b are 
consistently associated with cognitive deficits (Endele et al., 2010). Therefore, 
compromised NR2B expression in SCZ can contribute significantly to cognitive 
aberrations characteristic of this disorder.  
 
Transgenic animal models for SCZ 
 
 Transgenic mice manufactured to express mutations in genes implicated in the 
cognitive dysfunction observed in SCZ patients are another appealing tool used to 
develop models for SCZ. An NR1 hypomorph model in which mutant mice express a 
fraction (5%) of the constitutive subunit protein display cognitive deficits and motor 
phenotypes quite similar to pharmacological models for SCZ (Mohn et al., 1999). Further 
adding construct validity to this transgenic model, these behavioral phenotypes were 
recovered by haloperidol treatment, a typical antipsychotic (Mohn et al., 1999). However, 
this reinforces the lack of predictive validity given the ineptitude of these drugs to impede 
cognitive dysfunction in SCZ patients (Harvey and Keefe, 2001).  
  
 No single genetic aberration has yet been identified as sufficient or necessary for 
SCZ (Rodriguez-Murillo et al., 2012), which is surprising given the disorder’s high rate 
of heredity. Instead, it seems likely that a complex interplay among genetic susceptibility, 
environment, and epigenetic mechanisms contribute to the etiology of SCZ. Nonetheless, 
genetic models provide useful insights into the mechanisms that may be disrupted in the 
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SCZ brain. Importantly, many of these animal models express mutated genes that play 
critical roles in synaptogenesis, dopaminergic and glutamatergic synaptic physiology, and 
synaptic plasticity, hallmark processes of appropriate development and maturation of the 
brain, particularly the PFC. Of particular interest is the Disrupted in Schizophrenia 1 
(DISC1) gene, which has shown high co-segregation with SCZ and other major mental 
illnesses in a Swedish pedigree (Millar et al., 2000). This genetic abnormality was one of 
the first identified and implicated in SCZ (Brandon and Sawa, 2011); however, it is worth 
noting this model is one among many transgenic mutants that have been developed and 
characterized in the effort to solve the puzzle of SCZ. To date, a number of DISC1 
models have been developed, including those with point mutations in the endogenous 
Disc1 mouse gene, DISC1 C-terminal truncated mutants, and a model expressing the 
human truncated DISC1 protein isolated from the Swedish cohort (Pletnikov et al., 2008), 
which is used in this work. These varied genetic perturbations often yield behavioral 
outputs and morphological aberrations that are inconsistent across models and compared 
to the human condition.  
 
Focusing on the human truncated DISC1 (hDISC1) model developed by Dr. 
Mikhail Pletnikov and colleagues (Hikida et al., 2007; Pletnikov et al., 2008; Abazyan et 
al., 2010; Ayhan et al., 2011; Holley et al., 2013), these mutant mice exhibit impairments 
in working memory and cognitive flexibility tasks, as well as structural and 
morphological alterations reminiscent of abnormalities in SCZ patients (Pletnikov et al., 
2008; Jaaro-Peled et al., 2010). The specific consequences of the DISC1 mutation are 
unclear, but the protein product interacts with many partners from embryonic 
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development, including neurogenesis and neuronal migration, until adulthood, where it is 
valued in synaptic formation and maintenance (Brandon and Sawa, 2011). The role of 
DISC1 in brain development, functional maturation, and cognition is not yet fully 
understood; however, the value of this transgene’s models keeps them among the most 
commonly used tools currently available for SCZ research.  
 
Neurodevelopmental models for SCZ 
 
Alterations in NMDAR function during early postnatal development, such as 
juvenile or adolescent stages, can have profound neurodevelopmental and functional 
effects on cognitive capabilities in adulthood (Endele et al., 2010). Brief inhibition of 
NMDARs with the non-competitive antagonist ketamine in juvenile animals has long-
term effects on the inhibitory microcircuitry of the medial PFC (mPFC) and on 
prefrontal-dependent cognition, including working memory, associative learning, and 
attention (Jeevakumar et al., 2015). This unique combination of NMDAR inhibition 
during neurodevelopment, although not a recognized model for SCZ, does support the 
notion that NMDAR hypofunction during a critical period of PFC development can 
accurately mimic SCZ pathology in adulthood.  
 
A popular approach to model the neurodevelopmental aspect of SCZ is the use of 
environmental insults during gestation to evaluate the effects of this etiological factor. 
Among the most commonly employed neurodevelopmental models is the 
methylazoxymethanol (MAM) model for SCZ, which will be our focus. Mechanistically, 
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MAM causes transient DNA methylation selectively in actively proliferating neurons. 
MAM administration on progressive days of gestation (embryonic day, E), i.e. E15 and 
E17, results in starkly different effects on behavioral and morphological outcome 
measures. MAM exposure on E15 results in microcephaly and other gross brain 
abnormalities compared to E17-exposed offspring, which demonstrate cognitive, 
sensorimotor, and social perturbations specifically relevant to SCZ (Gourevitch et al., 
2004; Moore et al., 2006). The latter time point restricts the effect of MAM to cortical 
neurons, as opposed to the effects of MAM on a greater proportion of the developing 
brain at E15. Focusing on the E17 treatment paradigm, enlargement of the lateral 
ventricles and reductions in parvalbumin immunoreactivity in the adult MAM brain are 
well-matched to the most commonly reported structural and biochemical abnormalities in 
SCZ tissue (Lodge and Grace, 2009). Moreover, MAM animals exhibit deficits in 
learning (Gourevitch et al., 2004; Le Pen et al., 2006; Hazane et al., 2009; Snyder et al., 
2013) and rule reversal (Moore et al., 2006; Featherstone et al., 2007) in spatial working 
memory and attentional set-shifting tasks, respectively. Providing strong face validity for 
this model, MAM animals do not exhibit psychosis-like phenotypes until after puberty 
(Le Pen et al., 2006), yet demonstrate cognitive deficits in juvenile development (Snyder 
et al., 2013), mimicking the course of SCZ. However, these cognitive abnormalities are 
not always consistent with those reported in SCZ patients (Featherstone et al., 2007), and 
the MAM model has received much criticism in recent years. Nevertheless, it is another 
useful model for investigating the neurobiological aberrations underlying SCZ 
pathophysiology, providing a unique window into neurodevelopmental factors.  
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Epigenetics: an important level of regulation beyond genetics 
 
 DNA is the blueprint for organism development and function, encoding each 
critical aspect of the biological process. Another important layer contributing to this 
process is epigenetics, mechanisms which tightly control expression and repression of 
genes without any alteration to the DNA sequence. Over the past two decades, the role of 
epigenetic processes in chromatin stability, gene regulation, responding to environmental 
factors, and in disease states has grown rapidly (Allis and Jenuwein, 2016). These efforts 
have led to groundbreaking strides in other biomedical research fields, and provide an 
attractive avenue to explore the mechanisms of neuropsychiatric disorders. Given the 
complexity of both epigenetic processes and pathophysiology of psychiatric disorders, 
progress has been slow, yet promising.  
 
Basic tenets of epigenetic regulation 
 
  Genetic material can be packaged as euchromatin, which is DNA ready to be 
transcribed, and heterochromatin, a state during which the accessibility to DNA by the 
transcriptional machinery is difficult. These chromatin states are mediated by a very 
complex system of epigenetic regulation, including enzymes which “write” histone and 
DNA modifications, “readers” to interpret these markers as permissive or repressive gene 
states, and “erasers” that keep the epigenetic landscape and thus gene regulation dynamic 
(Nestler et al., 2016).  
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 Nucleosomes, the fundamental units of chromatin, are composed of a histone 
octamer core around which 147 base pairs of DNA are wrapped (Kornberg, 1974). The 
histone octamer consists of two copies of H2A, H2B, H3, and H4 proteins. The N-
terminal tails of these histone proteins contain amino acid residues, some of which can be 
dynamically modified (Verdin and Ott, 2015) by enzymes adding and removing acetyl 
and/or methyl groups (Jenuwein and Allis, 2001). The position and valence of these 
histone modifications contribute to the chromatin state within a genetic region. Regions 
of rich cytosine-guanine dyads (CpG islands) can undergo DNA methylation, commonly 
a marker of repressed gene expression (Adachi and Monteggia, 2014). Further adding to 
the complexity of this network, seemingly antagonistic histone modifications can co-
occur in promoter regions (Aranda et al., 2015), invalidating the notion that chromatin 
state is dictated by one class of modifications, i.e. permissive only vs repressive only. 
Lastly, these modifications are “erased” by enzymes or DNA excision mechanisms so 
that chromatin states exist only as needed, and are adapted to the changing needs of the 
organism. Much knowledge has been gained from ongoing research efforts, yet not all 
pieces of the puzzle are clear. Current efforts are focused on exploring how histone 
modifying enzymes are selectively recruited to target genes, how interactions among 
DNA methylated sites and modified histones contribute to gene regulation, how 
epigenetic markers at a single locus influence expression of distant and non-linear loci, 
among many other critical questions.  
 
Epigenetics in SCZ 
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 GWASs have identified numerous genetic mutations in post-mortem SCZ tissue, 
without a single genetic locus sufficient to induce the complex pathology seen in patients 
(Rodriguez-Murillo et al., 2012). The influence of epigenetic processes on gene 
expression patterns is transient, yet robust; thus, exploring epigenetic mis-regulation in 
SCZ opens provocative new possibilities for the mechanisms underlying the 
pathophysiology of this disorder. These efforts have led to interesting data from genes 
previously implicated in SCZ. One aspect of the glutamate hypothesis not explored in this 
work is NMDAR hypofunction on prefrontal interneurons and the associated functional 
implications for cognitive deficits in SCZ (Lewis et al., 2005). GAD1, the GABA-
synthesizing enzyme glutamic acid decarboxylase, is repressed in post-mortem SCZ 
tissue as shown by increased DNA (Huang and Akbarian, 2007) and histone methylation 
(Akbarian and Huang, 2006), as well as reduced acetylation markers (Huang et al., 2007). 
Further, long-range gene regulation of GAD1 is weakened in SCZ PFC, contributing to 
this repressed state of gene expression (Bharadwaj et al., 2013). Of note, similar long-
range epigenetic processes regulate the expression of Grin2b, the NR2B-encoding gene, 
implicating these mechanisms further in the NMDAR hypofunction hypothesis of SCZ 
(Bharadwaj et al., 2014). An important protein for neurodevelopment and neural 
migration, as well as synaptic NR2B function, is encoded by RELN, another gene found 
to be hyper-methylated in SCZ tissue (Abdolmaleky et al., 2005). Finally, SOX10 is also 
hyper-methylated in SCZ PFC (Yuan et al., 2013). This protein plays an important role in 
oligodendrocyte function, and its disruption may contribute to white matter abnormalities 
seen in SCZ post-mortem (Iwamoto et al., 2005).  
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 Together, these findings support a role for epigenetic mis-regulation in the PFC in 
SCZ, a region highly implicated in the cognitive deficits of the disorder. Surprisingly, this 
is a relative wealth of data compared to the absence of information from animal models. 
As this research progresses, we must take a careful and critical approach to the relevance 
of data from rodent models to that from humans. The unique complexity of epigenetic 
processes differs among neuronal sub-types and may be species-dependent as well. 
However, this shortcoming is already being addressed by work utilizing transgenic mouse 
models and human SCZ tissue concomitantly (Kurita et al., 2012).  
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CHAPTER 2: SPECIFIC AIMS 
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Schizophrenia (SCZ) is a severe mental disorder characterized by cognitive 
disruption, even prior to the initial psychotic episode. Cognitive dysfunction is the best 
indicator of functional outcome; however, current pharmacological therapies only 
alleviate positive symptoms of SCZ. In order to identify viable treatments for the 
cognitive symptoms, we must understand the underlying mechanisms of these deficits. 
The NMDAR has been widely implicated in SCZ pathology; pharmacological and 
transgenic models of NMDAR hypofunction recapitulate cognitive impairments seen in 
SCZ, such as working memory, attention, and cognitive flexibility. Importantly, these 
cognitive deficiencies manifest during early postnatal development, particularly in 
juvenile and adolescent stages. The NMDAR subunit NR2B is particularly important for 
working memory function. The NR2B-to-NR2A subunit switch is an epigenetically 
regulated process, and is critical in functional maturation of many brain regions. 
However, the NR2B subunit remains high in the PFC throughout development and into 
adulthood. In order to investigate how NMDARs are affected during development in 
SCZ, we employ two animal models: the neurodevelopmental MAM rat model and the 
transgenic hDISC1 mouse model. Our findings show aberrant NMDAR- and AMPAR- 
neurotransmission in the PFC of developing rats and mice. This proposal aims to further 
characterize the consequences of aberrant glutamatergic neurotransmission on synaptic 
physiology and to explore the mechanisms by which NMDAR hypofunction occurs in 
developing MAM animals and hDISC1 mice. We elucidated a mechanism of epigenetic 
mis-regulation that is aberrantly co-opted in the MAM PFC during development and 
contributes to juvenile NMDAR hypofunction.  
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Specific Aim 1: Determine the functional consequences of reduced synaptic NR2B 
protein levels in juvenile and adolescent MAM mPFC. 
 
Part 1: Evaluate the functionality of glutamatergic neurotransmission in the juvenile and 
adolescent mPFC following prenatal MAM exposure. Hypothesis: significant reductions 
in synaptic NMDAR protein will impair NMDAR-mediated currents but not AMPAR-
mediated currents.  
 
Part 2: Characterize post-synaptic NMDAR and AMPAR function in juvenile and 
adolescent MAM animals and determine the contribution of NR2B subunits to NMDAR-
mediated currents using a selective NR2B antagonist, Ro25-6981. Hypothesis: post-
synaptic NMDARs will be functionally impaired due to loss of the persistently expressed 
NR2B subunit in juveniles, as well as decreased levels of the constitutive NR1 subunit in 
adolescent MAM PFC. MAM animals will display diminished NMDAR activation, 
which will occlude the effect of Ro25 blockade due to substantial loss of NR2B-
containing NMDARs. AMPAR function will remain functionally intact during these 
developmental time points.  
 
Specific Aim 2: Elucidate the mechanism of epigenetic mis-regulation underlying 
NMDAR hypofunction during early postnatal development in the MAM model for 
schizophrenia. 
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Explore the epigenetic mechanisms by which NR2B protein is downregulated in juvenile 
MAM animals using chromatin immunoprecipitation (ChIP). Hypothesis: enrichment of 
repressor proteins and histone modifications at the Grin2b promoter will be aberrantly 
increased in juvenile MAM PFC resulting in hyper-repression of the gene. Other 
NMDAR subunit genes, Grin1 and Grin2a, will not show altered regulation by these 
epigenetic mechanisms. 
 
Specific Aim 3: Characterize NMDAR expression and assess synaptic physiology in 
the prefrontal cortex of juvenile hDISC1 mutant mice 
 
Part 1: Characterize synaptic NMDAR expression in juvenile PFC of hDISC1 mice 
constitutively expressing the truncated human DISC1 protein. Hypothesis: subunit 
expression patterns will indicate NMDAR hypofunction occurs during juvenile 
development of the mPFC in hDISC1 mice. 
 
Part 2: Assess the consequences of altered NMDAR subunit expression on synaptic 
glutamatergic neurotransmission in juvenile hDISC1 mPFC. Hypothesis: NMDAR-
mediated currents will be reduced in hDISC1 animals as a result of diminished synaptic 
NR2A protein. AMPAR-mediated currents will also be compromised in the context of 
hDISC1 expression and NMDAR hypofunction. 
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Abstract 
 
Schizophrenia (SCZ) is characterized not only by psychosis, but also by working 
memory and executive functioning deficiencies, processes that rely on the prefrontal 
cortex (PFC). Because these cognitive impairments emerge prior to psychosis onset, we 
investigated synaptic function during development in the neurodevelopmental 
methylazoxymethanol (MAM) model for SCZ. In particular, we focused on NMDA 
receptors (NMDARs), which are an important substrate for learning and memory 
throughout the brain and are extensively implicated in PFC-dependent cognition as well 
as SCZ pathogenesis. Using Western blot and whole-cell patch-clamp electrophysiology, 
we found that the levels of synaptic NR2B protein are significantly decreased in juvenile 
MAM animals, and the function of NMDARs is substantially compromised. Both 
NMDA-mEPSCs and synaptic NMDA-eEPSCs are significantly reduced in layer V 
pyramidal neurons. This protein loss during the juvenile period is correlated with an 
aberrant increase in enrichment of the epigenetic transcriptional repressor REST and the 
repressive histone marker H3K27me3 at the Grin2b promoter, as assayed by ChIP-qPCR. 
Glutamate hypofunction has been a prominent hypothesis in the understanding of SCZ 
pathology; however, little attention has been given to the NMDAR system in the 
developing PFC in models for SCZ. Our work is the first to confirm that NMDAR 
hypofunction is a feature of early postnatal development, with epigenetic hyper-
repression of the Grin2b promoter being a contributing factor. The selective loss of 
NR2B protein and subsequent synaptic dysfunction weakens PFC function during 
development and may underlie early cognitive impairments in SCZ models and patients.  
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Introduction 
 
 Glutamatergic hypofunction in the prefrontal cortex (PFC) is speculated to 
underlie cognitive symptoms (Lipska and Weinberger, 2000; Gainetdinov et al., 2001; 
Kantrowitz and Javitt, 2012) and contribute to the pathophysiology of schizophrenia 
(SCZ) (Coyle et al., 2002; Lau and Zukin, 2007; Snyder and Gao, 2013). Particularly, the 
N-methyl-D-aspartate receptor (NMDAR), a major glutamate receptor subtype, has 
received great attention (Martucci et al., 2006; Kristiansen et al., 2010; Weickert et al., 
2013). NMDARs are heterotetrameric complexes composed of the requisite NR1 subunit, 
as well as two subunits of either NR2 (A-D) or NR3 (A-B) (Paoletti et al., 2013). The 
subunit composition of NMDARs dictates their physiological properties, 
pharmacological sensitivity, and functional complexity (Paoletti et al., 2013). NR2A and 
NR2B subunits are predominantly expressed in the adult brain and are essential for 
synaptic plasticity (Monyer et al., 1994). In the PFC, NR2B-containing NMDARs 
(NR2B-NMDARs) on pyramidal neurons are necessary for the sustained firing activity 
required to maintain working memory function in response to incoming stimuli 
(Goldman-Rakic, 1995; Wang et al., 2008). Moreover, NR2B subunits are persistently 
expressed throughout PFC maturation (Wang et al., 2008), whereas other brain regions 
undergo an NR2B-to-NR2A subunit switch. This switch is an essential element of 
experience-dependent maturation of many brain areas (Dumas, 2005); however, PFC 
maturation is characterized by different developmental milestones (Monaco et al., 2015).  
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Deficits in NMDAR function, particularly NR2B-NMDARs, impair working 
memory (Wang et al., 2013), which is a constituent process of many higher-order 
cognitive capacities including cognitive flexibility and executive functioning (Goldman-
Rakic, 1995). These cognitive deficits, among others, are commonly reported in the SCZ 
population (Reichenberg, 2010) and are the best predictor of functional outcome (Bowie 
and Harvey, 2006). Notably, behavioral manifestations of impaired cognition are evident 
prior to psychosis in patients (Jones et al., 1994; Cannon et al., 2000; Rosso et al., 2000). 
Thus, a greater understanding of the developmental vulnerabilities that produce this early 
cognitive dysfunction is critical. 
 
We use the methylazoxymethanol acetate (MAM) neurodevelopmental model for 
SCZ to investigate PFC postnatal development, with a focus on NMDAR mis-expression 
(Gilmour et al., 2012). Lending both face and predictive validities to this model for SCZ, 
MAM animals demonstrate a greater degree of MK801-induced hyper-locomotion that is 
sensitive to treatment with antipsychotics (Moore et al., 2006; Lodge and Grace, 2009). 
Additionally, deficiencies in PFC-dependent cognition, including working memory and 
cognitive flexibility, are also evident in this model (Gourevitch et al., 2004; Flagstad et 
al., 2005; Lavin et al., 2005; Moore et al., 2006). Furthermore, MAM animals have 
altered hippocampal NMDAR expression, and impaired learning and memory function in 
juvenile and adolescent stages of development (Hradetzky et al., 2012; Snyder and Gao, 
2013), demonstrating the relevance of this model in assessing NMDAR hypofunction in 
early postnatal development. 
 
42 
 
Epigenetic mechanisms regulate glutamatergic gene expression in normal brain 
development (Stadler et al., 2005), with alterations in histone and DNA modifications 
implicated in neuropsychiatric disorders, including SCZ (Akbarian, 2010a; b; 2014; 
Nestler et al., 2016). A possible mechanism underlying NMDAR hypofunction is 
repression of glutamatergic genes within the PFC, as reported in post-mortem SCZ brain 
tissue (Numata et al., 2014). In fact, in the MAM model, aberrant histone modification 
patterns are evident in the developing medial PFC (mPFC) (Mackowiak et al., 2014). 
However, two major questions remain: (1) is NMDAR hypofunction evident in early 
postnatal development of the PFC in this SCZ model, and (2) is there an epigenetic 
mechanism that may contribute to this endophenotype? In the following experiments, we 
seek to address these questions by characterizing the expression profile, synaptic 
physiology, and regulation by epigenetic mechanisms of NMDARs in the PFC of 
juvenile MAM and saline animals.  
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Materials and Methods 
 
Animals 
 
All animal procedures were performed in accordance with the National Institutes 
of Health Guide for the Care and Use of Laboratory Animals and were approved by the 
Drexel University College of Medicine Institutional Animal Care and Use Committee. 
Adult pregnant Sprague-Dawley rats were purchased from Charles River Laboratories 
International, Inc. (Wilmington, MA) and were intraperitoneally (I.P.) injected with 25 
mg/kg methylazoxymethanol acetate (MAM) or vehicle (saline) on embryonic day 17 
(E17), as previously reported (Hradetzky et al., 2012; Snyder et al., 2013; Xing et al., 
2016). Pups were usually born on E21/P0, and were weaned and rehoused on postnatal 
day 21 (P21). Only male animals aged P17-23 (classified as juveniles (Spear, 2000; 
Wang and Gao, 2009; 2010)) were used in all experiments. 
 
Tissue collection and western blot for synaptosomal proteins 
 
Animals were anesthetized with Euthasol (0.2 ml kg−1, I.P.) until unresponsive to 
toe pinch, and then the brain was extracted. The brain region containing the PFC was 
dissected, homogenized in sucrose buffer (in mM: 320 sucrose, 4 HEPES-NaOH buffer, 
pH 7.4, 2 EGTA, 1 sodium orthovanadate, 0.1 phenylmethylsulfonyl fluoride, 50 sodium 
fluoride, 10 sodium pyrophosphate, 20 glycerophosphate, with 1 μg/ml leupeptin and 1 
μg/ml aprotinin), and then centrifuged at 1000 g for 10 minutes to remove large cell 
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fragments and nuclear materials. The resulting supernatant was centrifuged at 17,000 g 
for 15 minutes to yield cytoplasmic proteins in the supernatant. The pellet from this spin 
was re-suspended in homogenization buffer and centrifuged at 17,000 g for an additional 
15 minutes to yield washed synaptosomes. The synaptosomal fraction then was hypo-
osmotically lysed and centrifuged at 25,000 g for 20 minutes to yield synaptosomal 
plasma membranes in the pellet.  
 
A bicinchoninic acid (BCA) protein assay was performed to determine protein 
concentration. The protein sample was mixed with Laemmli sample buffer, boiled for 5 
minutes, and separated on a 7.5% SDS-PAGE gel. After electrophoresis, proteins were 
transferred to polyvinylidene difluoride membranes (EMD-Millipore, Billerica, MA). 
The membrane was blocked in 5% nonfat milk and probed with primary anti-serum. Each 
blot was probed for anti-mouse NR1 (Invitrogen, 32-5000, 1:5000, Carlsbad, CA), anti-
rabbit NR2A (EMD-Millipore, 04-901, 1:4000), anti-mouse NR2B (EMD-Millipore, 05-
920, 1:2000), anti-rabbit NR3A (EMD-Millipore, 07-356, 1:4000), anti-rabbit NR3B 
(Tocris, 2060, 1:4000), and anti-mouse actin (Sigma, A5316, 1:100,000, St Louis, MO), 
which was used as a loading control. The blots were incubated with horseradish 
peroxidase-coupled anti-rabbit or anti-mouse IgG secondary antibody (Vector 
Laboratories), and proteins were visualized using enhanced chemiluminescence (ECL 
Plus, Amersham Biosciences, Piscataway, NJ). Protein expression of each subunit was 
evaluated by densitometry using Image-J software. Additionally, samples from each 
animal were run at least 4 times to minimize interblot variance. Raw values for NMDAR 
subunit proteins were normalized to actin and this ratio was further normalized to the first 
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usable band on each membrane. The normalized values for each protein were averaged 
per animal to yield the mean and standard error per group. 
 
Whole-cell patch-clamp electrophysiology 
 
Male juvenile (aged P17-23) saline and MAM animals were anesthetized with 
Euthasol (0.2 ml kg−1, I.P.), the brains were removed, and coronal slices through the 
prelimbic PFC were cut (300 μm) into an ice-cold bath of oxygenated artificial 
cerebrospinal fluid (aCSF, in mM: 124 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 1 
MgSO4, 26 NaHCO3, and 10 dextrose, pH 7.4) using a VT-1200S vibratome tissue slicer 
(Leica Microsystems, Wetzlar, Germany). Slices were transferred to a holding chamber, 
submerged in oxygenated aCSF at 35°C for one hour and then remained at room 
temperature until used for recording. Slices were placed into a recording chamber 
mounted on an Olympus upright microscope (BX51, Olympus America, Center Valley, 
PA), where they were continuously bathed in oxygenated aCSF. Neurons were visualized 
with infrared differential interference video microscopy. All experiments were conducted 
with an Axon MultiClamp 700B amplifier (Molecular Devices), and data were acquired 
using pCLAMP 9.2 software and analyzed using Clampfit 10.2 software (Molecular 
Devices, Novato, CA).  
 
Spontaneous and miniature excitatory post-synaptic currents 
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To record AMPAR- and NMDAR-mediated spontaneous or miniature excitatory 
post-synaptic currents (EPSCs), somatic whole-cell voltage-clamp recordings were 
obtained from layer V pyramidal cells using patch electrodes with an open tip resistance 
of 5–7 MΩ (internal solution, in mM: 110 D-gluconic acid, 110 CsOH, 10 CsCl2, 1 
EGTA, 1 CaCl2, 5 QX-314, 1 ATP-Mg, 10 HEPES, at pH 7.3, adjusted with CsOH). In 
voltage-clamp mode, the membrane potentials were held at -70 mV in the presence of 
picrotoxin (50 μM) to record AMPAR-mediated spontaneous EPSCs (AMPA-sEPSCs), 
or with both picrotoxin and tetrodotoxin (TTX, 0.5 μM) for miniature EPSCs (AMPA-
mEPSCs). mEPSCs were recorded for at least 5 minutes and then DNQX (20 μM) was 
washed on to block AMPARs. When all currents ceased, the membrane potential was 
slowly ramped up to 60 mV. NMDA-mEPSCs were then recorded for at least 5 minutes. 
A typical s/mEPSC event was selected to create a sample template for event detections 
within a 5-min period for each data file. The frequency (number of events) and amplitude 
of the individual events were examined with the threshold set at the medium level (i.e., 5 
within a range of 1 to 9) in Clampfit. The detected events were then visually inspected to 
ensure specificity. 
 
Evoked excitatory post-synaptic currents 
 
To record evoked NMDAR-mediated EPSCs (NMDA-eEPSCs), a bipolar 
stimulating electrode was placed in layer II/III of the mPFC approximately 200-300 μm 
from visually-identified layer V pyramidal cells. Picrotoxin (50 µM) was used to block 
GABAAR-mediated neurotransmission. Cells were held at 60 mV to record NMDA-
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eEPSCs for 5 min before and 5 min after bath application of a selective NR2B antagonist 
Ro25-6981 (Ro25, 1 μM). EPSCs were evoked through the stimulating electrode using a 
physiologically relevant 10-pulse, 20 Hz train with a 0.1 Hz stimulating interval. 
Stimulus intensity was adjusted until 50-100 pA NMDA-eEPSC amplitude responses 
were achieved. Cells with an unstable baseline or unusual response patterns throughout 
recording were removed from the analysis. The EPSC recordings were monitored 
throughout each experiment by implementing a -100 pA current pulse with a 200 ms 
duration, and all cells with >20% change in series resistance during recording were 
discarded. Traces were analyzed for amplitude relative to the first post-stimulus baseline 
and cumulative charge (charge transfer, nA*ms), as well as paired-pulse ratio (PPR). 
 
Western blot for histone proteins 
 
PFC tissue was collected as described above. The Epiquik Total Histone 
Extraction Kit (OP-0006, Epigentek) was used to isolate the histone fraction. A BCA 
assay was used to determine protein concentration. After boiling in Laemmli buffer for 5 
minutes, 15 μg of protein were loaded on a 15% SDS-PAGE gel. After electrophoresis, 
blots were transferred to pore size 0.20 μm polyvinylidene difluoride membranes 
(Millipore, Billerica, MA). Membranes were blocked with 5% nonfat milk and separately 
probed with the following primary antibodies: H3K9ac (Abcam, ab10812, 1:5000, 
Cambridge, UK), H3K18ac (Abcam, ab1191, 1:5000), H3K27ac (Abcam, ab4729, 
1:5000), H3K27me3 (Abcam, ab6002, 1:2000), and total histone H3 (Novus, 1:100,000) 
was used as a loading control. Blots were incubated with horseradish peroxidase-coupled 
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anti-rabbit or anti-mouse IgG secondary antibody (Vector Laboratories, Burlingame, 
CA), and proteins were visualized using enhanced chemiluminescence (ECL Plus, 
Amersham Biosciences, Piscataway, NJ). Protein expression for each histone 
modification was evaluated by densitometry using Image-J software. Samples from each 
animal were run at least 4 times to minimize interblot variance.  
 
Chromatin immunoprecipitation and quantitative PCR assay 
 
PFC tissue was dissected from saline and MAM animals at P21 and pooled for the 
chromatin immunoprecipitation (ChIP) and quantitative PCR (qPCR) assays. Pooled 
samples from 4 saline and 4 MAM animals yielded the total tissue quantity (120 
mg/group) necessary for shearing using the truChIPTM Chromatin Shearing Kit (Covaris, 
PN520083, Woburn, MA) and E220 evolution Focused-ultrasonicator (Covaris, 
500239UPE). The chromatin was immunoprecipitated using the EZ-Magna ChIP™ A-
Chromatin Kit (EMD-Millipore; 17-408) and three separate reactions with 50 mg of 
sheared chromatin were carried out using: (i) 2 μg of REST antibody (EMD-Millipore; 
07-579), (ii) 1 μg H3K27me3 antibody (Abcam; ab6002), and (iii) a mock reaction 
containing all reagents with IgG as a control. To isolate the chromatin from these 
experiments, the antibodies and cross-linked histone modifications and modifying 
proteins were removed with repetitive washes and Proteinase K-mediated digestion. The 
eluted material was purified using a QIAquick PCR kit (Qiagen; 28104, Manchester, UK) 
and was directly used for qPCR. Positive and negative control primer sets were purchased 
from Active Motif (71027, 71024, Carlsbad, CA). PCRs were performed in a 20-μL 
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reaction containing purified chromatin DNA, 1 mΜ Power SYBR Green PCR Master 
Mix (Applied Biosystems; 4367659), and 10 mM of both forward and reverse primers 
(Table 1). PCR was performed in triplicate using an ABI 7500 system (Applied 
Biosystems, 4406985), yielding 6 data points per group. Fold change in DNA was 
determined by the ΔΔCt method. 
 
Table 1 
Forward primers Reverse primers
Grin2b (PR1) GGTCAAGCTGCCTCTCCAT GCAGAGCAGAAGGAAATGTATTCG
Grin2a TCCGGAGTGGAACAGAAAGC CTCATCCAGCCCCATGCT
Grin1 TCCCTGCTTCCTCTCTTGGA AATGACTGCTGGGAGCAAGAC
 
Forward and reverse primer sequences for Grin2b (proximal promoter region), 
Grin2a, and Grin1 used in ChIP-qPCR experiments.  
 
Data analysis 
 
Statistical analyses were carried out using SPSS Statistics version 24.0 (IBM, 
Armonk, NY). Normality and homogeneity of variance testing determined the use of 
parametric or non-parametric tests for each dataset. Protein expression analyses, AMPA- 
and NMDA-s/mEPSC amplitude and frequency, and ChIP-qPCR enrichment levels were 
compared using unpaired Student’s t-test or Mann-Whitney U tests. Enrichment of REST 
and H3K27me3 at Grin1, Grin2a, and Grin2b between groups and across promoter 
regions were analyzed using a One-Way ANOVA with a Tukey’s post-hoc. Evoked data 
were analyzed using repeated measures ANOVA to compare amplitude or charge transfer 
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between groups and across pulses. Student’s t-tests or Mann-Whitney U tests were used 
for analysis of amplitude or charge transfer at each pulse between groups. All data are 
presented as mean ± standard error (S.E.). Single, double, and triple asterisks represent 
p<0.05, p<0.01, and p<0.001, respectively. 
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Results 
 
NMDAR protein levels are reduced in the PFC of juvenile MAM rats 
 
 To determine if NMDARs are altered during prefrontal development in this SCZ 
model, we first examined how prenatal MAM exposure affects NMDAR protein levels in 
juvenile (P21) animals. We collected synaptic plasma membrane fractions from saline 
and MAM animals and probed for NMDAR subunit levels via Western blot. Actin was 
used as a loading control. We found no significant differences between saline and MAM 
animals in NR1, NR2A, NR2B, NR3A, or NR3B subunit levels at P14 (data not shown; 
Saline n=3-5 rats, MAM n=3-5 rats; p=0.651, p=0.360, p=0.892, p=0.172, and p=0.230, 
respectively). However, in the PFC of late juvenile (P21) MAM animals, there was a 
significant decrease in NR2B protein compared to saline animals (Figure 3; saline 
0.76±0.07, n=4; MAM 0.53±0.06, n=5; p=0.045). No difference was found for NR1, 
NR2A, NR3A, or NR3B levels at P21 (Saline n=4, MAM n=5; p=0.842, 0.170, 0.994, 
and 0.681, respectively). Together, these data indicate that prenatal MAM exposure alters  
NMDAR protein levels during the critical juvenile period of the developing PFC. Moving  
forward, experiments in juvenile animals encompassed the late juvenile (P21) time point. 
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Figure 3 
 
NR2B protein is reduced in synaptosomes from PFC of juvenile MAM animals. Left, 
representative Western blot bands, and right, summary graph, show NR2B protein is 
significantly reduced in synaptosomes from juvenile MAM PFC (NR2B: saline 
0.76±0.07, n=4; MAM 0.53±0.06, n=5; p=0.045). No difference at P21 was found for the 
other NMDAR subunits (saline n=4, MAM n=5; NR1 p=0.842, NR2A p=0.170, NR3A 
p=0.994, and NR3B p=0.681). 
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AMPA-s/mEPSCs are comparable between juvenile saline and MAM layer V pyramidal 
neurons in mPFC 
 
 We next sought to determine if the reduced NMDAR subunit protein levels in 
juvenile MAM animals resulted in altered glutamatergic neurotransmission. We utilized 
whole-cell patch-clamp to record from layer V pyramidal neurons in the mPFC and 
examined AMPA-s/mEPSCs, allowing us to understand the functional state of AMPARs 
in response to inputs from multiple brain regions. We first recorded sEPSCs that 
presumably resulted from action potentials of pre-synaptic neurons, as well as the 
spontaneous release of neurotransmitter at synapses, and then washed on tetrodotoxin to 
block action potentials in the slice and recorded mEPSCs. We held the cell at -70 mV 
with GABAAR function blocked to assess if MAM exposure had an effect on functional 
AMPARs and if there were changes in pre-synaptic function. We found no differences in 
either the frequency or amplitude of the AMPA-sEPSCs or -mEPSCs in juvenile (P17-
23) MAM and saline rats (Figure 4A; sEPSCs: frequency, Hz, saline 2.12±0.42, n=14 
cells; MAM 1.99±0.31, n=23 cells; p=0.731. Amplitude, pA, saline 17.80±1.29; MAM 
16.26±0.54, p=0.506. Figure 4B; mEPSCS: frequency, Hz, saline 1.34±0.32, n=13; 
MAM 2.28±0.66, n=15; p=0.387. Amplitude, pA, saline 14.27±0.59; MAM 14.33±1.02, 
p=0.961). 
 
Amplitude of NMDA-mEPSCs is diminished in juvenile MAM mPFC 
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We next held the cell at 60 mV while blocking GABAARs and AMPARs to 
examine changes in NMDAR function. In juveniles, we saw a significant decrease of 
NMDA-mEPSC amplitude, but not frequency, in MAM layer V mPFC neurons 
compared with those in saline animals (Figure 5; mEPSCs: frequency, Hz, saline 
1.16±0.18, n=14; MAM 1.51±0.38, n=11; p=0.424. Amplitude, pA, saline 32.06±2.98, 
MAM 20.73±2.12; p=0.007). Thus, prenatal MAM exposure impairs functional 
NMDARs, but not AMPARs, in the developing mPFC; however, it is unclear whether 
pre- or post-synaptic dysfunction contributes to deficient NMDAR neurotransmission.  
 
Juvenile MAM animals have a significant reduction in NMDARs in mPFC layer V 
pyramidal neurons 
 
To determine whether synaptic function of layer V pyramidal cells is affected by 
prenatal MAM exposure, we recorded NMDAR-mediated EPSCs evoked by stimulating 
layer II/III afferents with a 10-pulse, 20 Hz train. To evaluate the functional state of 
NMDARs during development, we compared the amplitude and charge transfer of the 
evoked EPSCs between saline and MAM animals. GABAAR-mediated neurotransmission 
was blocked with picrotoxin, and stimulation was adjusted until EPSC amplitudes of 50-
100 pA were achieved. We found that amplitudes of NMDA-eEPSCs are reduced in 
juvenile MAM animals (Figure 6; amplitude, pA, Saline n=10, MAM n=10, Repeated 
Measures ANOVA: group: F(1,18)=9.64, p=0.006, pulse: F(1.69, 30.43)=5.39, p=0.013; 
interaction: F(1.69, 30.43)=1.17, p=0.316). Post-hoc analysis reveals amplitude is 
significantly diminished in MAM animals at all 10 pulses (p<0.05). Similarly, charge 
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transfer of NMDA-eEPSCs is significantly reduced in MAM animals (Figure 6; charge 
transfer, nA*ms, Repeated Measures ANOVA: group: F(1,18)=7.36, p=0.014, pulse: 
F(1.06, 19.08)=55.51, p<0.001; interaction: F(1.06, 19.08)=6.25, p=0.020). Simple main 
effects analysis shows charge transfer is significantly decreased in juvenile MAM mPFC 
at all pulses (p<0.05). We did not find any changes in paired-pulse ratio (PPR), a measure 
of pre-synaptic release probability, which indicates these reductions in synaptic 
transmission are restricted to alterations in post-synaptic receptor function (Figure 6; 
t(18)=1.08, p>0.05). We also did not find any significant differences in stimulation 
intensity between the saline and MAM groups (Figure 6; U=42; p>0.05). Together, these 
data demonstrate a loss of post-synaptic NMDARs in layer V pyramidal neurons in 
juvenile MAM mPFC. 
 
Juvenile MAM layer V pyramidal cells exhibit a loss of NR2B-NMDARs 
 
To evaluate whether the NR2B protein loss seen in Western blot experiments and 
the reduction of synaptic NMDA-eEPSC responses reflects a loss of post-synaptic 
NR2B-NMDARs specifically, we bath-applied Ro25-6981 (Ro25, 1 μM), a selective 
NR2B antagonist, while holding the cell at 60 mV. Reductions in evoked NMDA 
amplitude and charge transfer following Ro25 treatment indicate a blockade of solely 
NR2B-NMDARs. Following bath application of Ro25 in saline cells, we found a 
significant reduction of NMDA-eEPSC amplitude (Figure 7A; amplitude, pA; Saline 
before Ro n=10, Saline after Ro n=8, group: F(1, 16)=5.04; p=0.039; pulse: F(1.36, 
21.69)=5.32, p=0.022; interaction: F(1.36, 21.69)=0.38, p=0.608; post-hoc: pulses 3-5, 
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p<0.05, pulses 1-2, 6-10, p>0.05). Surprisingly, charge transfer is only marginally 
diminished following Ro25 wash-on in saline cells (Figure 7A; charge transfer, nA*ms; 
group: F(1, 16)=3.06, p=0.10; pulse: F(1.05, 16.73)=38.02, p<0.001; interaction: F(1.05, 
16.73)=2.88, p=0.107; post-hoc: pulses 1&4, p<0.05, pulses 2-3, 5-10, p>0.05). 
However, bath application of Ro25 does not reduce amplitude or charge transfer in 
juvenile MAM animals, likely due to the significant loss of NMDARs (Figure 7B; 
amplitude, pA; MAM before Ro n=10, MAM after Ro n=9, group: F(1, 17)=0.43; 
p=0.519; pulse: F(1.83, 31.18)=3.42, p=0.049, interaction: F(1.83, 31.18)=0.25, p=0.763; 
charge transfer, nA*ms; group: F(1, 17)=0.19, p=0.671; pulse: F(1.05, 17.79)=38.85, 
p<0.001; interaction: F(1.05, 17.79)=13.90, p=0.691). Post-hoc analyses reveal no 
significant differences in amplitude or charge transfer between saline or MAM animals 
after Ro25 treatment. Thus, we can conclude synaptic NR2B-NMDARs are reduced in 
juvenile MAM animals as confirmed by the occlusion of Ro25’s effect on layer V 
pyramidal cells in juvenile MAM mPFC. 
  
Synaptic AMPARs remain functionally intact in juvenile MAM mPFC  
 
 To further confirm AMPAR function is unchanged following prenatal MAM 
exposure, we evaluated the effect of layer II/III stimulation on AMPA-eEPSCs in saline 
and MAM layer V pyramidal neurons. To record AMPA-eEPSCs, the cells were held at -
70 mV in the presence of picrotoxin (50 µM) to block GABAAR-mediated 
neurotransmission. EPSCs were evoked as described above; stimulation intensity was 
increased until 50-100 pA responses were elicited. We found no significant differences in 
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amplitude or charge between juvenile saline and MAM animals (Figure 8; amplitude, pA, 
Saline n=11, MAM n=9, Repeated Measures ANOVA: group: F(1,18)=3.09, p=0.096, 
pulse: F(2.49, 44.84)=17.16, p<0.001; interaction: F(2.49, 44.84)=0.88, p=0.441. Charge 
transfer, nA*ms, Repeated Measures ANOVA: group: F(1,18)=0.77, p=0.391, pulse: 
F(1.03, 18.57)=64.09, p<0.001; interaction: F(1.03, 18.57)=0.77, p=0.395). Post-hoc 
analysis further confirmed no significant differences in amplitude or charge transfer 
between saline and MAM animals. In addition, there were no significant differences in 
PPR or stimulation intensity between the two groups (Figure 8; PPR: saline 1.03±0.05, 
MAM 0.89±0.11, t(11.66)=1.25, p=0.236. Stimulation intensity: saline 247.36±45.40, 
MAM 256.44±79.65, U=37.5, p=0.370). Together, these data confirm that hypofunction 
of NR2B-NMDARs is unique to juvenile MAM mPFC. 
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Figure 4 
 
AMPAR-mediated neurotransmission is unaffected in juvenile mPFC by prenatal 
MAM exposure. (A) AMPA-sEPSCs are not significantly affected by prenatal MAM 
exposure. sEPSCs: frequency, Hz, saline 2.12±0.42, n=14 cells; MAM 1.99±0.31, n=23 
cells; p=0.731; amplitude, pA, saline 17.80±1.29; MAM 16.26±0.54, p=0.506. (B) 
AMPA-mEPSCs are also not significantly different between saline and MAM mPFC. 
mEPSCS: frequency, Hz, saline 1.34±0.32, n=13; MAM 2.28±0.66, n=15; p=0.387; 
amplitude, pA, saline 14.27±0.59; MAM 14.33±1.02, p=0.961. 
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Figure 5 
 
NMDAR neurotransmission is selectively impaired in juveniles following prenatal 
MAM exposure. Juvenile NMDA-mEPSCs have significantly reduced amplitude (right 
traces), but no change in frequency of currents. mEPSCs: frequency, Hz, saline 
1.16±0.18, n=14; MAM 1.51±0.38, n=11; p=0.387; amplitude, pA, saline 32.06±2.98, 
MAM 20.73±2.12; p=0.007. 
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Figure 6 
 
The number of NMDARs is diminished in layer V pyramidal neurons of juvenile 
MAM mPFC. Using repeated measures ANOVA with pulse as a within-subject factor 
and group as a between-subjects factor, there is a significant group effect on both 
amplitude and charge transfer of NMDA-eEPSCs. At each pulse, there is a significant 
decrease in both amplitude and charge transfer in juvenile MAM animals. Amplitude, 
pA, Saline n=10, MAM n=10, Repeated Measures ANOVA: group: F(1,18)=9.64, 
p=0.006, pulse: F(1.69, 30.43)=5.39, p=0.013; interaction: F(1.69, 30.43)=1.17, p=0.316; 
post-hoc: pulses 1-10, p<0.05. Charge transfer, nA*ms, Repeated Measures ANOVA: 
group: F(1,18)=7.36, p=0.014, pulse: F(1.06, 19.08)=55.51, p<0.001; interaction: F(1.06, 
19.08)=6.25, p=0.020; post-hoc: pulses 1-10, p<0.05. There were no significant 
differences in PPR (t(18)=1.08, p>0.05) or stimulation intensity between the saline and 
MAM groups (U=42; p>0.05). 
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Figure 7 
 
Synaptic NR2B-NMDARs are selectively diminished in juvenile MAM animals. (A) 
Ro25, an NR2B antagonist, significantly decreases the amplitude of saline NMDA-
eEPSCs, with strongly trending effects on charge transfer. Amplitude, pA; Saline before 
Ro n=10, Saline after Ro n=8, group: F(1, 16)=5.04; p=0.039; pulse: F(1.36, 21.69)=5.32, 
p=0.022; interaction: F(1.36, 21.69)=0.38, p=0.608; post-hoc: pulses 3-5, p<0.05, pulses 
1-2, 6-10, p>0.05. Charge transfer, nA*ms; group: F(1, 16)=3.06, p=0.10; pulse: F(1.05, 
16.73)=38.02, p<0.001; interaction: F(1.05, 16.73)=2.88, p=0.107; post-hoc: pulses 1&4, 
p<0.05, pulses 2-3, 5-10, p<0.10. (B) Ro25 does not significantly decrease amplitude or 
charge transfer of NMDA-eEPSCs in MAM animals. Amplitude, pA; MAM before Ro 
n=10, MAM after Ro n=9, group: F(1, 17)=0.433; p=0.519; pulse: F(1.83, 31.18)=3.42, 
p=0.049; interaction: F(1.83, 31.18)=0.25, p=0.763. Charge transfer, nA*ms; group: F(1, 
17)=0.187, p=0.671; pulse: F(1.05, 17.79)=38.85, p<0.001; interaction: F(1.05, 
17.79)=13.90, p=0.691. Post-hoc analyses reveal no significant differences in amplitude 
or charge transfer in MAM mPFC after Ro25 treatment.  
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Figure 8 
 
AMPA-eEPSCs are functionally intact in MAM layer V pyramidal neurons 
compared to saline mPFC. Using repeated measures ANOVA, we found no significant 
differences in amplitude or charge across pulses between juvenile saline and MAM 
animals. Amplitude, pA, Saline n=11, MAM n=9, group: F(1,18)=3.09, p=0.096, pulse: 
F(2.49, 44.84)=17.16, p<0.001; interaction: F(2.49, 44.84)=0.88, p=0.441. Charge 
transfer, nA*ms, group: F(1,18)=0.77, p=0.391, pulse: F(1.03, 18.57)=64.09, p<0.001; 
interaction: F(1.03, 18.57)=0.77, p=0.395). Post-hoc analysis further confirmed no 
significant differences at each pulse in amplitude or charge transfer between saline and 
MAM animals. In addition, there were no significant differences in PPR (saline 
1.03±0.05, MAM 0.89±0.11, t(11.66)=1.25, p=0.236) or stimulation intensity (saline 
247.36±45.40, MAM 256.44±79.65, U=37.5, p=0.370) between the two groups. 
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H3K27me3 is selectively increased in the PFC of juvenile MAM rats 
 
To evaluate whether epigenetic mechanisms may be implicated in regulating 
NMDAR expression during postnatal development, we assayed a number of histone 
modifications relevant to learning and memory processes. This exploratory approach 
would lend insight into whether a mis-regulation of the epigenome underlies juvenile 
NMDAR hypofunction in the MAM model for SCZ. We collected PFC tissue from saline 
and MAM animals at P21 and processed the tissue to isolate the histone fraction. Using 
Western blotting to determine levels of acetylation and methylation on histone H3, we 
found juvenile MAM animals had a significant increase in H3K27me3 (Figure 9; Saline 
0.93±0.04, n=5; MAM 1.05±0.01, n=6; p=0.045), but no change in the acetylation 
markers assayed (H3K9ac, p=0.263; H3K18ac, p=0.524; H3K27ac, p=0.294). These data 
suggest epigenetic modifications are facilitating the NR2B protein loss observed in the 
juvenile MAM PFC. We further tested this possibility using ChIP-qPCR as described 
below. 
 
The proximal promoter region of Grin2b is highly enriched in the transcriptional 
repressor REST and the histone marker H3K27me3 in juvenile MAM PFC 
 
Our findings thus far reveal a marked increase of the repressive epigenetic marker 
H3K27me3 with concomitant reduction of NR2B protein levels and functional NR2B-
NMDARs in juvenile MAM PFC. Using the evidence of increased H3K27me3 in 
juvenile MAM PFC, we carried out ChIP-qPCR assays to measure the enrichment levels 
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of the repressor protein REST and repressive histone marker H3K27me3 at the proximal 
promoter region of the Grin2b gene (NR2B-encoding). Grin2b has response element 
(RE1) motifs within its promoter region to which REST can be recruited (Rodenas-Ruano 
et al., 2012). To test the specificity of REST-mediated repression, we also assessed the 
enrichment levels of REST at the RE1 sites of Grin1 (NR1-encoding) and Grin2a 
(NR2A-encoding). For saline controls, we found REST was significantly enriched at 
Grin2b, but not at Grin1 or Grin2a RE1 sites (Figure 10A; saline REST, One-Way 
ANOVA, group: Grin2b 20.86±5.23, n=4 rats yielding 6 data points from qPCR; Grin2a 
3.85±1.04; Grin1 3.05±1.13; F(2, 17)=9.17, p=0.003; Tukey’s post-hoc: saline Grin2b vs 
Grin2a, p=0.005; saline Grin2b vs Grin1, p=0.007; saline Grin2a vs Grin1, p=0.985). 
Similarly, repressive marker H3K27me3 was significantly enriched at the Grin2b site, 
but not at the Grin1 or Grin2a RE1 sites in saline PFC (Figure 10B; saline H3K27me3, 
One-Way ANOVA, group: Grin2b 230.03±19.24, n=4; Grin2a 102.82±28.49; Grin1 
57.88±12.41; F(2, 17)=17.91, p<0.001; Tukey’s post-hoc: saline Grin2b vs Grin2a, 
p=0.002; saline Grin2b vs Grin1, p<0.001; saline Grin2a vs Grin1, p=0.316). Together, 
these data demonstrate that REST is normally more highly enriched within the proximal 
promoter region of Grin2b than at either Grin1 or Grin2a RE1 sites. This confirms the 
selective role of REST in regulating Grin2b expression, as has been shown in the 
hippocampus (Rodenas-Ruano et al., 2012). Further, repressive marker H3K27me3 
enrichment at the Grin2b promoter region, but not at Grin1 or Grin2a, lends evidence to 
the notion that Grin2b expression is tightly regulated by these mechanisms compared to 
these other major NMDAR subunit proteins.  
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In contrast, the proximal promoter of Grin2b in MAM animals has a significant 
increase of REST enrichment in the PFC compared to saline controls (Figure 10A; REST 
Grin2b: saline 20.86 ±5.23, n=4; MAM 66.10 ± 13.28, n=4; p=0.017). We found that 
enhanced enrichment of REST binding at Grin2b is accompanied by a significant 
increase in H3K27me3 levels (Figure 10B; H3K27me3 Grin2b: saline 230.03 ± 19.24; 
MAM 9752.23 ± 598.3; p<0.001). Of note, we did observe an increased level of 
H3K27me3 in the MAM PFC at the Grin2a RE1 site (Figure 10B; H3K27me3 Grin2a: 
saline 102.82 ± 28.49, MAM 2258.43 ± 774.18; p=0.019). Such enrichment is not 
associated with increased REST enrichment at this Grin2a RE1 site (Figure 10A; REST 
Grin2a: saline 3.85±1.04, MAM 5.85±2.14; p=0.420). Moreover, we did not observe a 
significant difference in REST or H3K27me3 enrichment at the Grin1 promoter region in 
saline versus MAM animals, suggesting MAM exposure does not induce transcriptional 
regulation at this Grin1 RE1 site (Figure 10; REST Grin1: saline 4.59±1.13, MAM 
3.05±0.40; p=0.230; H3K27me3 Grin1: saline 57.88±12.41, MAM 49.18±6.27; 
p=0.546). Thus, in comparing levels of REST and H3K27me3 at RE1 sites of NMDAR-
expressing genes Grin1, Grin2a, and Grin2b between saline and MAM animals, it is 
evident that the extent of REST and H3K27me3 enrichment is far greater than that 
observed in control PFC, indicating that the Grin2b promoter region is in a hyper-
repressed state in juvenile MAM PFC. We conclude that this hyper-repression in MAM 
PFC in part contributes to the decrease in synaptic NR2B protein and NR2B-NMDAR 
hypofunction evident in prior experiments. 
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Figure 9 
 
Epigenetic histone marker H3K27me3 is selectively increased in developing MAM 
animals. Left, representative Western blot bands and, right, scatterplot demonstrates that 
histone marker H3K27me3 is selectively upregulated in juvenile MAM PFC. Saline 
0.93±0.04, n=5; MAM 1.05±0.01, n=6; p=0.045, but no change in the acetylation 
markers assayed (H3K9ac p=0.263, H3K18ac p=0.524, and H3K27ac p=0.294). 
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Figure 10 
 
REST-mediated repression of Grin2b at the proximal promoter region correlates 
with reduced synaptic NR2B protein in juvenile MAM animals. (A) Representative 
scatterplots depicting elevated REST repression of Grin2b in saline and MAM animals 
compared to other promoter regions, Grin2a and Grin1. REST Grin2b: saline 
20.86±5.23, MAM 66.10±13.28, p=0.017. REST Grin2a: saline 3.85±1.04, MAM 
5.85±2.14; p=0.420. REST Grin1: saline 4.59±1.13, MAM 3.05±0.40; p=0.230. In 
addition, REST enrichment is specific to Grin2b in the juvenile PFC. Saline REST, One-
Way ANOVA, group: F(2, 17)=9.17, p=0.003; Tukey’s post-hoc: saline Grin2b vs 
Grin2a, p=0.005; saline Grin2b vs Grin1, p=0.007; saline Grin2a vs Grin1, p=0.985. 
MAM REST, One-Way ANOVA, group: F(2, 17)=21.01, p<0.001; Tukey’s post-hoc: 
MAM Grin2b vs Grin2a, p<0.001; MAM Grin2b vs Grin1, p<0.001; MAM Grin2a vs 
Grin1, p=0.965. (B) H3K27me3 levels are significantly elevated at Grin2b and Grin2a in 
MAM animals, but not at Grin1, compared to saline animals. H3K27me3 Grin2b: saline 
230.03±19.24; MAM 9752.23±598.3; p<0.001. H3K27me3 Grin2a: saline 102.82±28.49, 
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MAM 2258.43±774.18; p=0.019. H3K27me3 Grin1: saline 57.88±12.41, MAM 
49.18±6.27; p=0.546. H3K27me3 enrichment is significantly increased in saline animals 
at Grin2b, compared to Grin2a and Grin1. Saline H3K27me3, One-Way ANOVA, 
group: F(2, 17)=17.91, p<0.001; Tukey’s post-hoc: saline Grin2b vs Grin2a, p=0.002; 
saline Grin2b vs Grin1, p<0.001; saline Grin2a vs Grin1, p=0.316. MAM animals show a 
similar trend in H3K27me3 enrichment at the subunit RE1 sites, as well as a significant 
enrichment at the Grin2a promoter. MAM H3K27me3, One-Way ANOVA, group: F(2, 
17)=81.05, p<0.001; Tukey’s post-hoc: MAM Grin2b vs Grin2a, p<0.001; MAM Grin2b 
vs Grin1, p<0.001; MAM Grin2a vs Grin1, p=0.036. 
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Discussion 
 
In these experiments, we explored the glutamate hypofunction hypothesis by 
measuring NMDAR subunit expression and function in the developing PFC using the 
neurodevelopmental MAM rat model for SCZ. Our findings provide the first direct 
evidence that NMDAR hypofunction is occurring at an early (juvenile) stage of 
development in the MAM model for SCZ. Specifically, synaptic NR2B protein 
expression is significantly decreased in the mPFC. Concomitantly, NMDAR-mediated 
neurotransmission is deficient as evidenced by reduced amplitude of NMDA-mEPSCs 
and diminished synaptic NMDAR-mediated current in juvenile MAM PFC layer V 
pyramidal neurons. Mechanistically, epigenetic mechanisms demonstrate a key role in 
this NR2B-related dysfunction. REST repressor protein is preferentially localized to the 
RE1 site in the Grin2b proximal promoter, but not to RE1 sites in the promoters of other 
major NMDAR subunit genes, Grin1 or Grin2a. Additionally, a functional marker of 
transcription, H3K27me3, is significantly increased at the Grin2b promoter in juvenile 
MAM PFC. Together, these data suggest that epigenetic mis-regulation of NR2B 
expression underlies NMDAR hypofunction in the PFC of juvenile animals in the MAM 
model for SCZ (Figure 11). 
 
Pharmacological, neurodevelopmental, and transgenic mouse models are used 
extensively to understand the role of NMDARs in SCZ (Kantrowitz and Javitt, 2010; 
Gilmour et al., 2012; Kantrowitz and Javitt, 2012; Snyder and Gao, 2013). However, 
conclusions drawn from previous work remain incomplete given that this research often 
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focuses on investigation of the adult brain, albeit cognitive dysfunction emerges early in 
development and precedes psychosis (Jones et al., 1994; Cannon et al., 2000; Rosso et al., 
2000). Indeed, transient antagonism of NMDARs during the juvenile period can elicit 
commonly reported SCZ-like endophenotypes in adulthood (Jeevakumar et al., 2015). 
These results corroborate our findings in the MAM model; NMDAR hypofunction in 
juveniles, in the form of reduced NR2B-NMDARs, precedes dopaminergic 
hypersensitivity, diminished social interaction (Flagstad et al., 2004), sensorimotor gating 
deficits, and perseverative behavior in cognitive flexibility (Moore et al., 2006), akin to 
positive, negative, and cognitive symptoms reported in SCZ patients (Elliott et al., 1995; 
Laruelle, 2000; Geyer et al., 2001). This is an important indicator that NMDAR 
hypofunction may emerge in early postnatal development, such as the juvenile stage of 
PFC development in SCZ.  
 
NMDAR hypofunction in juvenile MAM PFC is specifically due to reduced 
NR2B protein expression and function at the post-synaptic site, as evidenced by the 
smaller amplitude of NMDA-mEPSCs and evoked NMDAR-mediated currents. The 
NR2B subunit is integral for promoting persistent activity, which is the proposed 
molecular correlate of working memory function (Goldman-Rakic, 1995; Wang et al., 
2013). Because NR2B levels remain persistently high in the PFC throughout 
development and adulthood (Wang et al., 2008), the selective loss of NR2B-NMDARs in 
MAM PFC results in a vulnerability to working memory impairments (Snyder et al., 
2013; Xing et al., 2016). NR2B protein levels are substantially reduced, as shown by 
Western blot analysis, but this approach cannot distinguish the laminar specificity of this 
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deficiency. To this end, we used a selective blocker of NR2B, Ro25, to confirm the loss 
of synaptic NR2B-NMDARs in layer V neurons. In the saline group, Ro25 treatment 
reduces the amplitude of NMDAR-mediated currents by 57% at the first pulse, and 
approximately 50% at each proceeding pulse (range 49-55%). However, in the MAM 
group, NMDA amplitude is reduced by only 22% (range 14-26%). The significant loss of 
post-synaptic NMDARs in MAM cells occludes the predicted effect of Ro25 compared to 
saline cells, confirming a significant reduction in specifically NR2B-NMDARs in MAM 
PFC (Figure 7B).  
 
Since glutamate hypofunction emerged as a potential neurobiological 
underpinning of SCZ, efforts have focused on identifying the mechanism underlying this 
molecular disruption. Single-nucleotide polymorphisms (SNPs) and other genetic 
disturbances implicate Grin2b in psychiatric disorders, including SCZ (Qin et al., 2005; 
Endele et al., 2010; Jiang et al., 2010; Jia et al., 2012; Weickert et al., 2013; Akbarian, 
2014; Fromer et al., 2014). Indeed, complex higher-order chromatin conformations are 
involved in regulating gene expression and eventually, cognitive function. For example, 
rare SNPs in distal gene locations can, in fact, disrupt Grin2b expression and affect 
working memory function in both humans and mice (Bharadwaj et al., 2014). Therefore, 
a highly complex network of genetic and epigenetic processes is implicated in how 
glutamatergic genes may become dysregulated in SCZ.  
 
We sought to identify how the NR2B subunit was diminished in MAM PFC 
without substantial alterations of other NMDAR subunit protein levels. To address this 
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question, we looked to a well-characterized molecular process, the NR2B-to-NR2A 
subunit switch, in which NR2B protein levels are significantly decreased while NR2A 
protein expression is augmented to promote functional maturation of critical brain 
regions (Dumas, 2005; Rodenas-Ruano et al., 2012; Monaco et al., 2015). This process is 
tightly controlled by an epigenetic mechanism that is dependent upon the repressor REST 
and its corepressor protein partners (Tamminga and Zukin, 2015). Though it is unclear 
what dictates the specificity of REST for Grin2b compared to other NMDAR promoters, 
this pattern has been shown in these experiments and others (Rodenas-Ruano et al., 
2012). Thus, we hypothesized that this endogenous repressive mechanism of Grin2b 
expression is responsible, at least in part, for the selective reduction in NR2B protein 
observed in juvenile MAM animals via aberrant hyper-repression of the Grin2b 
promoter. Our work is the first to reveal REST is a selective regulator of Grin2b 
expression in the juvenile PFC in the MAM model for SCZ, with no significant 
enrichment at the Grin1 or Grin2a promoters (Figure 10A).  
 
Histone modifications can serve as functional readouts of chromatin state 
(Akbarian, 2010b). Altered histone modification patterns have been reported in the 
developing PFC of MAM animals (Mackowiak et al., 2014), indicating aberrant 
epigenetic processes contribute to abnormal PFC development in this model. Specifically, 
the repressive histone modification H3K27me3 is implicated in cellular vulnerability in 
SCZ tissue (Kano et al., 2013), reinforcing the contribution of this modification to neural 
dysfunction in the human condition. However, information regarding the specific location 
of these histone modification changes in the genetic landscape is lacking. Here, we 
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confirm that the increase in H3K27me3 in juvenile MAM PFC, as shown in Western 
blots, is also evident at the Grin2b site. This is likely due to the REST-mediated 
recruitment of Polycomb complex PRC2, which contains a catalytic enzyme domain, 
EZH2, responsible for the H3K27me3 modification (Kim and Kim, 2012). Importantly, 
these processes are transient regulators of gene expression. Thus, our focus was on the 
intermediate stage (P21) of juvenile development in order to measure H3K27me3 
enrichment levels concomitant with NR2B protein loss in the PFC.  
 
Surprisingly, there is also a significant increase of H3K27me3 enrichment at 
Grin2a in MAM PFC, although the levels of REST are not significantly enriched at this 
promoter and protein levels of NR2A are not altered by this enrichment. As shown by our 
ChIP experiments, a pattern of H3K27me3 enrichment exists in saline animals across 
promoters; that is, levels of this histone modification are highest at Grin2b, lower at 
Grin2a, and lowest at Grin1 (Grin2b > Grin2a > Grin1). Interestingly, MAM animals 
show a similar pattern of H3K27me3 enrichment in the PFC, although to a much higher 
degree. Compared to saline PFC, the level of H3K27me3 enrichment is 41-fold higher at 
Grin2b, while the enrichment at Grin2a is only 21-fold higher in MAM PFC. We 
hypothesize levels of H3K27me3 are elevated by a REST-independent mechanism at the 
Grin2a promoter. In fact, shRNA-mediated knockdown of REST does not significantly 
affect NR2A mRNA levels (Rodenas-Ruano et al., 2012), supporting the notion that 
significant enrichment of H3K27me3 levels at Grin2a in MAM PFC are likely 
independent of REST. Alternatively, modifications such as H3K4me3 and H3K36me3 
balance the chromatin state by mitigating the effects of repressive histone modifications, 
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prohibiting alterations to gene expression (Aranda et al., 2015). We propose an initial 
increase of H3K27me3 levels at the Grin2b promoter disrupts the balance of histone 
modifications, eventually recruiting REST for further EZH2-mediated enrichment of 
H3K27me3, resulting in reduced NR2B protein levels. However, at the Grin2a promoter, 
this threshold has likely not been surpassed by the 21-fold increase in H3K27me3. 
Further, the levels of other histone modifications, including the mutually exclusive 
marker H3K27ac, are unknown at these promoter regions. Therefore, more complex 
mechanisms are likely regulating expression of Grin2a, cumulatively resulting in no 
change to NR2A protein levels.  
 
We have previously demonstrated the persistent expression of NR2B in PFC 
compared to other cortical regions (Wang et al., 2008). Therefore, alterations in NR2B 
protein in the PFC throughout development and adulthood can have a great impact on 
circuitry and behavior (Tang et al., 1999; Cui et al., 2011; Monaco et al., 2015). The 
aberrant decrease in synaptic NR2B-NMDARs during juvenile development of MAM 
animals can affect signaling cascade activation, facilitation in response to incoming 
stimuli, and working memory and higher-order cognitive abilities (Monaco et al., 2015). 
These disruptions to the NMDAR system in the PFC and hippocampus (Snyder et al., 
2013), particularly during brain development, impose a vulnerability upon the critical 
fine-tuning of the network necessary for normal cognition in adulthood. Given the 
importance of the hippocampus-mPFC pathway in cognitive functioning (Marquis et al., 
2006) (Marquis et al., 2008), future experiments will explore the cognitive profile of 
juvenile MAM rats with a focus on PFC-dependent processes, such as working memory 
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and cognitive flexibility. Due to the continued lack of successful treatments for cognitive 
impairments in SCZ (Lett et al., 2014), even in the face of improved positive and 
negative symptoms, these deficits will persist as will the psychological and monetary 
burden of this disorder. These data are a contribution to the ever-growing force to 
understand the neurobiological underpinnings of the highly complex and devastating 
etiology of SCZ. 
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Figure 11 
 
Schematic depiction of synaptic dysfunction in juvenile MAM layer V pyramidal 
neurons (top) and epigenetic hyper-repression of the Grin2b promoter by REST and 
H3K27me3 (bottom).  
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CHAPTER 4: ALTERED NMDAR SUBUNIT COMPOSITION IN ADOLESCENT 
PFC IN THE MAM MODEL FOR SCHIZOPHRENIA 
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Abstract 
 
 Development of the prefrontal cortex (PFC) is characterized by refinement of the 
local microcircuitry, pruning of excitatory synapses, and the final stages of myelination. 
Adolescence is a critical period during which these processes are ongoing, and are 
particularly vulnerable to genetic or environmental perturbations. The prolonged time 
course of PFC maturation during late adolescence and early adulthood further increases 
its susceptibility to molecular aberrations. In addition to pruning and cellular maturation, 
the neurobiological mechanisms of adolescent brain development include alterations in 
N-methyl-D-aspartate receptors (NMDARs). In particular, NMDARs exhibit increased 
incorporation of the NR2B subunit, a proposed molecular correlate of working memory 
function. Thus, interrupting these developmental processes can have devastating effects 
on cognition and executive functioning. Schizophrenia (SCZ) is a debilitating mental 
illness often diagnosed during late adolescence and early adulthood, coinciding with 
these critical maturational processes. Considered a neurodevelopmental disorder, at-risk 
individuals exhibit cognitive and mood abnormalities during these critical developmental 
periods. However, it is yet unknown the molecular processes which may be affected 
during development. Thus, we employed the neurodevelopmental methylazoxymethanol 
(MAM) model to investigate synaptic NMDAR physiology during adolescent 
development. We found glutamatergic neurotransmission is significant affected by 
gestational MAM exposure, specifically due to downregulation of synaptic NMDAR 
subunits NR1 and NR2B. Further, NMDAR-mediated currents are significantly 
diminished in adolescent MAM animals. Interestingly, we revealed the subunit 
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composition of synaptic NMDARs in adolescent MAM animals are predominantly 
diheteromeric, while NMDARs in saline animals exhibit triheteromeric subunit 
arrangement. This functional alteration implicates NMDAR dysfunction during 
adolescent development in the neurodevelopmental MAM model for SCZ, and indicate 
complex mechanisms of glutamatergic dysfunction may be evident in the human illness.  
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Introduction 
 
Proper brain development at critical prenatal and postnatal stages is critical for 
appropriate function in adulthood (Cannon et al., 2002). During early development, 
synapses are strengthened at variable rates depending on their frequency of activation by 
external stimuli. This period of high neuroplasticity results in an overabundance of 
synapses that can be highly functional or less-often utilized, resulting in an energy-
inefficient network (MacAskill et al., 2010). Thus, synaptic pruning is a mechanism by 
which relatively weak synaptic contacts are removed so the brain is able to communicate 
in an energy-efficient manner once fully mature. Synaptic pruning is evident throughout 
the brain during each developmental stage; however, the prefrontal cortex (PFC) is 
unique in that it undergoes the latest and most protracted functional maturation (Kolb et 
al., 2012). Pruning is influenced by environmental inputs and is tightly regulated by 
changes in gene expression. PFC development during adolescence is a landmark stage of 
functional maturation characterized by refinement of the cortical circuitry; these 
processes include the final stages of myelination, maturation of interneurons, innervation 
of dopaminergic afferents, and pruning of excitatory synapses (Jaaro-Peled et al., 2009; 
Kolb et al., 2012). Thus, adolescence represents a highly vulnerable period of PFC 
development due to these critical changes in synaptic connectivity among excitatory 
neurons, interneurons, and neuromodulator systems (Kolb et al., 2012; Arnsten and Jin, 
2014). Although this stage is transient, environmental inputs or genetic aberrations can 
strongly affect these processes such that abnormalities in decision-making, behavioral 
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flexibility, and working memory, among many other PFC-dependent cognitive functions, 
emerge in adulthood (Gilmour et al., 2012). 
 
In addition to circuit-level changes in the PFC during adolescence, molecular 
changes are a critical component of functional maturation. The glutamatergic system is 
an integral mediator of neuroplasticity during development, as well as appropriate 
behavioral responses to stimuli in adulthood. Pre-synaptic release of glutamate coincident 
with AMPAR- and NMDAR-mediated depolarization of the post-synaptic membrane 
serves to maintain and strengthen synaptic connections. Importantly, the composition of 
these receptors dictates the physiological properties of neurons across development 
(Paoletti et al., 2013). In the adult PFC, NR2B-containing NMDARs (NR2B-NMDARs) 
maintain sustained firing of Delay cells, the proposed molecular mechanism of normal 
working memory function (Goldman-Rakic, 1995; Wang et al., 2008; Wang et al., 2013; 
Flores-Barrera et al., 2014). A delicate balance of NR2B-NMDAR activation promotes 
Delay cell firing in the preferred direction without overstimulating activity of non-
preferred direction firing. Pharmacological inhibition of NR2B-NMDARs reduces the 
signal-to-noise ratio of persistent activity during the delay phase of working memory 
tasks (Wang et al., 2013), disrupting the fine-tuned network of the PFC (Goldman-Rakic, 
1996). Alternatively, aberrant increases in NR2B protein can increase NMDAR activity, 
enhance long-term potentiation (LTP), and augment working memory and other cognitive 
functions (Tang et al., 1999; Cui et al., 2011). Thus, changes in NMDAR subunit protein 
expression and composition has a dynamic role in cognition; increased NR2B levels in 
adulthood can strengthen pre-existing cortical connections and promote cognition. 
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However, such alterations during juvenile and adolescent development can sensitize the 
brain to cognitive dysfunction later in life (Jeevakumar et al., 2015; Monaco et al., 2015; 
Xing et al., 2016; Li et al., 2017). 
 
Schizophrenia (SCZ) is a devastating, chronic mental illness that clinically 
manifests during late adolescence or early adulthood, during and immediately after these 
critical stages of NMDAR and PFC development (Konradi and Heckers, 2003). This 
neurodevelopmental disorder is characterized by psychosis, deficits in social cognition, 
and cognitive impairments. Although imaging studies demonstrate brain abnormalities 
during onset of SCZ (Cannon et al., 2002), behavioral and neurological abnormalities are 
evident even prior to diagnosis (Cannon and Jones, 1996; Marenco and Weinberger, 
2000; Chung et al., 2017). PFC tissue from post-mortem adult SCZ patients reveal 
reductions in spine density (Glantz and Lewis, 2000), neuropil volume (Goldman-Rakic 
and Selemon, 1997), and defective connectivity (Lewis and Lieberman, 2000), which are 
thought to result from aberrant brain development, manifesting as functional changes 
during adolescence and adulthood (Konradi and Heckers, 2003). Post-mortem analysis 
further reveals synaptic abnormalities in adolescent cortex and hippocampus, supporting 
the hypothesis that crucial neural circuits are altered in SCZ prior to adulthood 
(Goldman-Rakic and Selemon, 1997; Lewis et al., 2005; Tamminga et al., 2010). 
Neurobiological evidence of normal adolescent PFC development and how this differs 
from neurodevelopmental disorders is lacking (Lee et al., 2014). Particularly, it is yet 
unclear whether changes in NR2B and NMDAR expression and function occur in SCZ 
during adolescent PFC development. To address this question, we used the 
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neurodevelopmental methylazoxymethanol (MAM) model, which recapitulates structural 
and behavioral endophenotypes seen in adult SCZ patients (Moore et al., 2006; Lodge 
and Grace, 2009), to evaluate the physiological consequences of alterations in NMDAR 
subunit expression on the adolescent PFC.  
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Methods 
 
Animals 
 
All animal procedures were performed in accordance with the National Institutes 
of Health Guide for the Care and Use of Laboratory Animals and were approved by the 
Drexel University College of Medicine Animal Care and Use Committee. Food and water 
were provided ad libitum throughout the experiments. Pairs of adult pregnant Sprague-
Dawley rats were purchased from Charles River Laboratories International, Inc. 
(Wilmington, MA) to arrive on embyronic day 15 (E15). Dams were injected IP with 
either 25 mg/kg MAM or saline on E17. Pups were usually born on E21 or postnatal day 
0 (P0) and were weaned on P21. Male and female rats were group-housed by gender after 
weaning. Both female and male tissue was collected; however, only male tissue was used 
in the experiments outlined below. For all experiments, offspring aged P42-49 were 
characterized as adolescents (Kolb et al., 2012). 
 
Tissue collection and western blot for synaptosomal proteins 
 
PFC tissue was collected and processed as described in Chapter 3. Briefly, 
adolescent animals were perfused with 60 mL HEPES-buffered sucrose (in mM: 320 
sucrose, 4 HEPES-NaOH buffer, pH 7.4, 2 EGTA, 1 sodium orthovanadate, 0.1 
phenylmethylsulfonyl fluoride, 10 sodium fluoride, and 10 sodium pyrophosphate). The 
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brain region containing the PFC was dissected and homogenized in sucrose buffer. The 
homogenate was process to yield a synaptosomal fraction. 
 
A BCA protein assay was performed to determine protein concentration. The 
protein sample was mixed with Laemmli sample buffer, boiled for 5 minutes, and 
separated on a 7.5% SDS-PAGE gel. After electrophoresis, proteins were transferred to 
pore size 0.45 μm polyvinylidene difluoride membranes (PVDF, EMD-Millipore, 
Billerica, MA). The membrane was blocked in 5% nonfat milk and probed with primary 
anti-serum. Each blot was probed for anti-mouse NR1 (1:5000), anti-rabbit NR2A 
(1:4000), anti-mouse NR2B (1:2000), anti-rabbit NR3A (1:4000), anti-rabbit NR3B 
(1:4000), and anti-mouse actin (1:100,000), which was used as a loading control. The 
blots were incubated with horseradish peroxidase-coupled anti-rabbit or anti-mouse IgG 
secondary antibody (1:5000), and proteins were visualized using ECL Plus. Protein 
expression of each subunit was evaluated by densitometry using ImageJ software. 
Samples from each animal were run at least 4 times to minimize interblot variance. Raw 
values for NMDAR subunit proteins were normalized to actin and this ratio was further 
normalized to the first usable band on each membrane. These normalized values were 
averaged per animal to yield the final values which comprised the mean and standard 
error per group.  
 
Whole-cell patch-clamp electrophysiology 
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Animals were anesthetized with Euthasol (0.2 ml kg−1, IP) until unresponsive to 
toe pinch and perfused with ice-cold sucrose solution (in mM: 87 NaCl, 2.5 KCl, 1.25 
NaH2PO4, 25 NaHCO3, 75 sucrose, 25 glucose, 0.5 CaCl2, 7.0 MgSO4, pH 7.4) to 
preserve tissue quality. The brains were dissected, and 300 μm coronal slices containing 
the prelimbic PFC were cut into an ice-cold bath of oxygenated ice-cold sucrose solution 
using a VT-1200S vibratome tissue slicer (Leica Microsystems, Wetzlar, Germany). 
Slices were transferred to a holding chamber, submerged in oxygenated (95% O2, 5% 
CO2) aCSF (in mM: 124 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2, 1 MgSO4, 
and 10 dextrose, pH 7.4) at 35oC, for one hour and then remained at room temperature 
until used for recording. Slices were placed into a recording chamber mounted on an 
Olympus upright microscope (BX51, Olympus America, Center Valley, PA), where they 
were continuously bathed in oxygenated aCSF and maintained at 36oC. Neurons were 
visualized with infrared differential interference video microscopy. All experiments were 
conducted with an Axon MultiClamp 700B amplifier (Molecular Devices), and data were 
acquired using pCLAMP 9.2 software and analyzed using Clampfit 10.2 software 
(Molecular Devices).  
 
Spontaneous and miniature excitatory post-synaptic currents 
 
To record spontaneous or miniature EPSCs, somatic whole-cell voltage-clamp 
recordings were obtained from layer V pyramidal cells using patch electrodes with an 
open tip resistance of 8-11 M (CsCl2 intracellular solution, in mM: 110 D-gluconic 
acid, 110 CsOH, 10 CsCl2, 1 EGTA, 1 CaCl2, 5 QX-314, 1 ATP-Mg, 10 HEPES, at pH 
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7.3, adjusted with CsOH). Resting membrane potential was observed in current clamp 
mode for 1 to 2 minutes to confirm cell health. In voltage clamp mode, the membrane 
potentials were first held at -70 mV in the presence of picrotoxin (50 μM) to record 
AMPAR-mediated spontaneous EPSCs (AMPA-sEPSCs), which are a result of both 
action potential-mediated and stochastic release of glutamate, in the absence of 
GABAAR-mediated neurotransmission. After 5 minutes of recording, tetrodotoxin (TTX, 
0.5 μM) was added to the wash-on buffer to isolate miniature EPSCs (AMPA-mEPSCs). 
TTX blocks Na2+ channels, thus prohibiting action potential-stimulated release of 
neurotransmitter. mEPSCs were recorded for at least 5 minutes and then DNQX (20 μM) 
was washed on to block AMPARs. When all currents ceased, the membrane potential 
was slowly ramped up to 60 mV. NMDAR-mediated mEPSCs (NMDA-mEPSCs) were 
then recorded for at least 5 minutes.  
 
A typical s/mEPSC event was selected to create a sample template for event 
detections within a 5-minute period for each data file. The frequency (number of events) 
and amplitude of the individual events were examined with the threshold set at the 
medium level (i.e., 5 within a range of 1 to 9) in Clampfit. The detected events were then 
visually inspected to ensure specificity. 
 
Evoked excitatory post-synaptic currents 
 
To record evoked EPSCs (eEPSCs), a bipolar stimulating electrode was placed in 
layer II/III of the mPFC approximately 200-300 μm from visually-identified layer V 
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pyramidal cells. Picrotoxin (50 µM) was used to block GABAAR-mediated 
neurotransmission. Cells were held at -70 mV to record AMPA-eEPSCs for 5 mins in the 
presence of picrotoxin (50 µM). Then the membrane potential was held at 60 mV to 
record NMDA-eEPSCs for 5 minutes before and 5 minutes after bath application of a 
selective NR2B antagonist Ro25-6981 (Ro25, 1 μM). EPSCs were evoked through the 
stimulating electrode using a physiologically relevant 10-pulse, 20 Hz train with a 0.1 Hz 
stimulating interval. Stimulus intensity was adjusted until 50-100 pA amplitude responses 
were achieved. Cells with an unstable baseline or unusual response patterns throughout 
recording were removed from the analysis. The EPSC recordings were monitored 
throughout each experiment by implementing a -100 pA current pulse with a 200 ms 
duration, and all cells with >20% change in series resistance during recording were 
discarded. Traces were analyzed for amplitude (pA) relative to the first post-stimulus 
baseline and cumulative charge (charge transfer, nA*ms), as well as paired-pulse ratio 
(PPR). 
 
Data Analysis 
 
Statistical analyses were carried out using SPSS Statistics version 24.0 (IBM). 
Normality and homogeneity of variance testing determined the use of parametric or non-
parametric tests for each dataset. Protein expression analyses, and AMPA- and NMDA-
s/mEPSC amplitude and frequency were compared using unpaired Student’s t-test or 
Mann-Whitney U test. Evoked data were analyzed using repeated measures ANOVA to 
compare amplitude or charge transfer between groups and across pulses. In the event of a 
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significant interaction effect, the results of a simple main effects analysis are reported. 
All data are presented as mean  standard error (S.E.). Single, double, and triple asterisks 
represent p<0.05, p<0.01, and p<0.001, respectively. 
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Results 
 
Constitutive NMDAR subunit NR1 is significantly decreased in adolescent MAM PFC 
 
To determine if NMDARs are altered during prefrontal cortical development in 
this neurodevelopmental SCZ model, we first examined how prenatal MAM exposure 
affects NMDAR protein levels in adolescent (P42-P49) saline and MAM PFC. We 
collected synaptic plasma membrane fractions from saline and MAM animals, and 
probed for NMDAR subunits, including NR1, NR2A, NR2B, NR3A, and NR3B. Actin 
was used as a loading control. At this developmental time point, MAM animals had 
significantly lower synaptic NR1 protein levels (Figure 12; NR1: saline 1.10±0.10, n=7; 
MAM 0.77±0.09, n=8; t(13)=2.43, p=0.030). Additionally, synaptic NR2B levels are 
decreased, although not significantly (NR2B: saline 1.20±0.10, n=7; MAM 0.96±0.05, 
n=8; t(9.23)=2.29, p=0.054). We found no changes in synaptic NR2A, NR3A, or NR3B 
proteins between groups (p>0.05). 
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Figure 12 
 
Synaptic NR1 protein is significantly reduced in adolescent MAM PFC, with a non-
significant decrease in NR2B protein. Left, representative Western blot bands, and 
right, summary scatterplots illustrating a significant reduction in synaptic NR1 levels in 
adolescent MAM PFC (NR1: saline 1.10±0.10, n=7; MAM 0.77±0.09, n=8; p=0.030). 
We observed a strongly trending reduction in NR2B levels that did not reach 
significance, and no significant differences in other synaptic NMDAR subunits between 
adolescent saline and MAM animals (NR2B: saline 1.20±0.10; MAM 0.96±0.05; 
p=0.054. NR2A: saline 1.19±0.08; MAM 1.09±0.05; p=0.311. NR3A: saline 0.99±0.04; 
MAM 0.94±0.05; p=0.515. NR3B: saline 1.21±0.10; MAM 1.04±0.02; p=0.237).  
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NMDA-mEPSCs, but not AMPA-s/mEPSCs, have significantly diminished frequency in 
adolescence following prenatal MAM exposure 
 
We next sought to determine if the reduced NMDAR subunit protein levels in 
adolescent MAM animals altered glutamatergic neurotransmission. We utilized whole-
cell patch clamp electrophysiology to record from layer V pyramidal neurons in the 
mPFC and examined both NMDA- and AMPA-EPSCs. We first recorded sEPSCs that 
presumably resulted from action potentials of pre-synaptic neurons as well as the 
spontaneous release of neurotransmitter at synapses, and then washed on tetrodotoxin 
(TTX, 0.5 µM) to block action potentials in the slice and recorded mEPSCs. We held the 
cell at -70mV while blocking GABAAR function, to assess if MAM exposure had an 
effect on functional AMPARs and pre-synaptic function. We found no significant 
changes in AMPA-sEPSCs or -mEPSCs in adolescent MAM compared to saline animals 
(Figure 13A; AMPA-sEPSCs: frequency, Hz, saline 2.72±1.05, n=10; MAM 2.17±0.58, 
n=14; p=0.285; amplitude, pA, saline 21.8±3.19, MAM 19.12±1.37, p=0.285. Figure 
13B; mEPSCs, frequency, Hz, saline 1.49±0.26, n=11; MAM 2.06±0.69, n=12; p=0.566; 
amplitude, pA, saline 17.80±0.86, MAM 17.63±0.70, p=0.878).  
  
We next held the cell at +60mV while blocking GABAARs and AMPARs to 
examine changes in NMDAR function. Adolescent MAM animals showed significantly 
reduced NMDA-mEPSC frequency, and a trend toward increased amplitude (Figure 14; 
NMDA-mEPSCs: frequency, Hz, saline 1.47±0.45, n=10; MAM 0.627±0.13, n=10; 
p=0.005; amplitude, pA, saline 24.71±2.82; MAM 31.4±2.0; p=0.069).  
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Synaptic NMDAR function is comparable between adolescent saline and MAM mPFC 
 
 To further evaluate the functional consequences of prenatal MAM exposure on 
NMDARs, we recorded NMDA current in layer V pyramidal neurons evoked by 
stimulation of layer II/III cells with a 10-pulse, 20 Hz train. After 50-100 pA responses 
were stable for 5 mins, we recorded NMDA-eEPSCs in the presence of picrotoxin (50 
µM). Surprisingly, we found no significant differences in amplitude and charge transfer 
between adolescent saline and MAM animals (Figure 15; amplitude, pA, Saline n=9, 
MAM n=11, Repeated Measures ANOVA: group: F(1,18)=0.18, p=0.678, pulse: F(2.39, 
43.02)=40.21, p<0.001; interaction: F(2.39, 43.02)=2.26, p=0.107. Charge transfer, 
nA*ms, Repeated Measures ANOVA: group: F(1,18)=0.80, p=0.383, pulse: F(1.04, 
18.66)=59.20, p<0.001; interaction: F(1.04, 18.66)=0.41, p=0.538). Further, the 
stimulation intensity required to elicit this magnitude of responses was not significantly 
different between groups (saline 82.77±13.71, MAM 101.46±15.37, t(18)=-0.89, 
p=0.386). In addition, pre-synaptic release probability is not affected by MAM exposure 
as we found no difference in PPR compared to saline cells (saline 0.65±0.06, MAM 
0.66±0.09, t(18)=-0.12, p=0.904). Given the loss of synaptic NR1, substantial reduction 
of NR2B protein, and hypofunction of NMDA-mEPSCs, these findings are unexpected. 
However, we continued to probe the function of NR2B-NMDARs in the adolescent 
MAM mPFC with the NR2B-selective antagonist, Ro25.  
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Adolescent MAM animals demonstrate diheteromeric NMDAR subunit composition 
compared to triheteromeric NMDARs in saline animals 
 
 To compare the levels of NR2B-NMDARs between adolescent saline and MAM 
layer V pyramidal neurons, we bath-applied Ro25 (1 µM), a selective NR2B antagonist. 
Knowing NR2B levels are persistent in PFC through development, we found Ro25 
blocked a significant portion (45-60%) of NR2B-mediated NMDA current in the control 
condition (Figure 16A; amplitude, pA, Saline before Ro25 n=9, saline after Ro25 n=7, 
Repeated Measures ANOVA: group: F(1,14)=5.16, p=0.039, pulse: F(2.54, 
35.50)=19.61, p<0.001; interaction: F(2.54, 35.50)=5.40, p=0.005). Simple main effects 
analysis showed saline layer V pyramidal cells treated with Ro25 had a significant 
reduction in amplitude at pulses 1 to 4 (p<0.05), but not at pulses 5 to 10. Similarly, the 
charge conducted through NR2B-NMDARs was significant diminished following Ro25 
wash-on (Figure 16A; charge transfer, nA*ms, Repeated Measures ANOVA: group: 
F(1,14)=4.33, p=0.056, pulse: F(1.02, 14.24)=28.14, p<0.001; interaction: F(1.02, 
14.24)=2.42, p=0.141). Saline cells treated with Ro25 demonstrated a significant loss of 
current during pulses 1 to 6 (p<0.05), but not at pulses 7 to 10.  
  
In adolescent MAM mPFC, Ro25 wash-on resulted in drastic effects to NR2B-
mediated NMDA current. The amplitude and current of NMDA-eEPSCs was 
significantly diminished in the presence of Ro25 (Figure 16B; amplitude, pA, MAM 
before Ro25 n=11, MAM after Ro25 n=8, Repeated Measures ANOVA: group: 
95 
 
F(1,17)=19.76, p<0.001, pulse: F(2.18, 37.07)=18.26, p<0.001; interaction: F(2.18, 
37.07)=16.70, p<0.001. Charge transfer, nA*ms, Repeated Measures ANOVA: group: 
F(1,17)=21.79, p<0.001, pulse: F(1.04, 17.67)=24.82, p<0.001; interaction: F(1.04, 
17.67)=14.84, p=0.001). Further, simple main effects analysis revealed substantial loss of 
NMDA-eEPSC amplitude (p<0.01) and current (p<0.001) following Ro25 treatment of 
MAM cells. That Ro25 exerts a much greater effect on NMDA current in MAM animals 
compared to saline animals strongly suggests the subunit composition of NMDARs is 
altered in MAM mPFC. In fact, it indicates that NMDARs in MAM mPFC are 
homodimers of NR1 and NR2B subunits, while NMDARs in saline animals are 
heterotetramers of NR1/NR2B/NRX subunits.  
 
Post-synaptic AMPARs are unaffected in adolescent MAM mPFC, yet pre-synaptic 
release mechanisms may be enhanced 
 
 To evaluate whether MAM exposure has detrimental effects on AMPAR-
mediated neurotransmission in the adolescent mPFC, we compared EPSCs in layer V 
pyramidal neurons evoked by layer II/III stimulation between saline and MAM animals. 
We found AMPA-eEPSCs remain uncompromised during the adolescent period in MAM 
mPFC. There were no significant differences in amplitude or charge of AMPA-eEPSCs 
between the two groups (Figure 17; amplitude, pA, Saline n=11, MAM n=10, Repeated 
Measures ANOVA: group: F(1,19)=0.07, p=0.798, pulse: F(2.07, 39.28)=32.70, p<0.001; 
interaction: F(2.07, 39.28)=0.17, p=0.853. Charge transfer, nA*ms, Repeated Measures 
ANOVA: group: F(1,19)=0.18, p=0.674, pulse: F(1.06, 20.18)=64.09, p<0.001; 
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interaction: F(1.06, 20.18)=0.32, p=0.592). In addition, there was no significant 
difference in stimulation intensity required to elicit AMPA-eEPSCs in MAM cells 
compared to saline cells (saline 264.76±65.90, MAM 224.80±74.83, t(19)=0.90, 
p=0.359). Interestingly, we did observe a significant increase in PPR in adolescent MAM 
mPFC compared to saline cells (saline 0.88±0.05, MAM 1.09±0.05, t(18)=-2.80, 
p=0.012). 
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Figure 13 
 
AMPA-s/mEPSCs are functionally intact in adolescent MAM mPFC. We found no 
significant changes in (A) AMPA-sEPSCs or (B) -mEPSCs in adolescent MAM 
compared to saline animals (A; AMPA-sEPSCs: frequency, Hz, saline 2.72±1.05, n=10; 
MAM 2.17±0.58, n=14; p=0.285; amplitude, pA, saline 21.8±3.19, MAM 19.12±1.37, 
p=0.285. B; mEPSCs, frequency, Hz, saline 1.49±0.26, n=11; MAM 2.06±0.69, n=12; 
p=0.566; amplitude, pA, saline 17.80±0.86, MAM 17.63±0.70, p=0.878).   
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Figure 14 
 
Adolescent MAM animals showed significantly reduced NMDA-mEPSC frequency, 
and a trend toward increased amplitude. We found a significant increase in NMDA-
mEPSC frequency, and a trend of increased amplitude in NMDA currents from layer V 
pyramidal cells in MAM mPFC compared to saline cells (NMDA-mEPSCs: frequency, 
Hz, saline 1.47±0.45, n=10; MAM 0.627±0.13, n=10; p=0.005; amplitude, pA, saline 
24.71±2.82; MAM 31.4±2.0; p=0.069). 
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Figure 15 
 
Synaptic NMDARs in saline and MAM adolescent mPFC are functionally 
comparable. We found no significant differences in amplitude and charge transfer 
between adolescent saline and MAM animals (Amplitude, pA, Saline n=9, MAM n=11, 
Repeated Measures ANOVA: group: F(1,18)=0.18, p=0.678, pulse: F(2.39, 
43.02)=40.21, p<0.001; interaction: F(2.39, 43.02)=2.26, p=0.107. Charge transfer, 
nA*ms, Repeated Measures ANOVA: group: F(1,18)=0.80, p=0.383, pulse: F(1.04, 
18.66)=59.20, p<0.001; interaction: F(1.04, 18.66)=0.41, p=0.538). The stimulation 
intensity required to elicit this magnitude of responses was not significantly different 
between groups (saline 82.77±13.71, MAM 101.46±15.37, t(18)=-0.89, p=0.386). In 
addition, pre-synaptic release probability is not affected by MAM exposure as we found 
no difference in PPR (saline 0.65±0.06, MAM 0.66±0.09, t(18)=-0.12, p=0.904).  
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Figure 16  
 
Adolescent MAM animals display properties of diheteromeric NR2B-NMDARs, 
while saline animals exhibit functional properties of triheteromeric 
NR1/NRX/NR2B-NMDARs. (A) We found Ro25 blocked a significant portion (45-
60%) of NR2B-mediated NMDA current in the control condition (amplitude, pA, Saline 
before Ro25 n=9, saline after Ro25 n=7, Repeated Measures ANOVA: group: 
F(1,14)=5.16, p=0.039, pulse: F(2.54, 35.50)=19.61, p<0.001; interaction: F(2.54, 
35.50)=5.40, p=0.005; simple main effects: pulses 1-4 p<0.05). Similarly, the current 
conducted through NMDARs was significant diminished following Ro25 wash-on of 
saline cells (charge transfer, nA*ms, Repeated Measures ANOVA: group: F(1,14)=4.33, 
p=0.056, pulse: F(1.02, 14.24)=28.14, p<0.001; interaction: F(1.02, 14.24)=2.42, 
p=0.141; Student’s t-test post-hoc: pulses 1-6, p<0.05). (B) In adolescent MAM mPFC, 
the amplitude and current of NMDA-eEPSCs was significantly diminished in the 
presence of Ro25 (amplitude, pA, MAM before Ro25 n=11, MAM after Ro25 n=8, 
Repeated Measures ANOVA: group: F(1,17)=19.76, p<0.001, pulse: F(2.18, 
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37.07)=18.26, p<0.001; interaction: F(2.18, 37.07)=16.70, p<0.001; simple main effects: 
all pulses, p<0.01. Charge transfer, nA*ms, Repeated Measures ANOVA: group: 
F(1,17)=21.79, p<0.001, pulse: F(1.04, 17.67)=24.82, p<0.001; interaction: F(1.04, 
17.67)=14.84, p=0.001; simple main effects: all pulses: p<0.001). 
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Figure 17 
 
Synaptic AMPAR physiology is not affected by MAM exposure, yet pre-synaptic 
glutamate release is enhanced. We found no differences in amplitude or change of 
AMPA-eEPSCs between adolescent saline and MAM animals (amplitude, pA, Saline 
n=11, MAM n=10, Repeated Measures ANOVA: group: F(1,19)=0.07, p=0.798, pulse: 
F(2.07, 39.28)=32.70, p<0.001; interaction: F(2.07, 39.28)=0.17, p=0.853. Charge 
transfer, nA*ms, Repeated Measures ANOVA: group: F(1,19)=0.18, p=0.674, pulse: 
F(1.06, 20.18)=64.09, p<0.001; interaction: F(1.06, 20.18)=0.32, p=0.592). In addition, 
there was no significant difference in stimulation intensity between saline and MAM cells 
(saline 264.76±65.90, MAM 224.80±74.83, t(19)=0.90, p=0.359). However, we observed 
a significant increase in PPR in adolescent MAM mPFC (saline 0.88±0.05, MAM 
1.09±0.05, t(18)=-2.80, p=0.012). 
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Global levels of histone modifications are not altered in adolescent MAM PFC 
  
In order to explore one possible mechanism underlying the reduced expression of 
NR1 and NR2B, we used Western blot to probe levels of histone modifications that have 
been implicated in cognitive processes as well as psychiatric disorders. Adolescent saline 
and MAM PFC was used to probe for H3K9ac, H3K18ac, H3K27ac, H3K27me3, with 
total H3 protein serving as the normalizing protein. We found no significant differences 
in any of these modifications during adolescent development between saline and MAM 
PFC (Figure 18: H3K9ac: saline 1.16±0.07, n=5; MAM 1.18±0.04, n=4; t(7)=-0.25, 
p=0.810; H3K18ac: saline 1.06±0.02, MAM 1.06±0.02; t(7)=0.10, p=0.924; H3K27ac: 
saline 1.13±0.12, MAM 1.30±0.15; t(7)=-0.853, p=0.422; H3K27me3: saline 1.32±0.18, 
MAM 1.43±0.12; t(7)=-0.472, p=0.651).  
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Figure 18 
 
No significant differences in histone modifications between adolescent saline and 
MAM PFC. Permissive acetylation markers and a repressive methylation marker was 
assayed using Western blot to compare histone modification patterns between saline and 
MAM animals during adolescent PFC development (H3K9ac: saline 1.16±0.07, n=5; 
MAM 1.18±0.04, n=4; p=0.810. H3K18ac: saline 1.06±0.02, MAM 1.06±0.02; p=0.924. 
H3K27ac: saline 1.13±0.12, MAM 1.30±0.15; p=0.422. H3K27me3: saline 1.32±0.18, 
MAM 1.43±0.12; p=0.651). 
 
105 
 
Discussion 
 
Mental health care costs present the largest economic burden worldwide, and 
diseases that emerge before adulthood cost approximately 10% more than those 
diagnosed in later life (Lee et al., 2014). However, it is estimated the National Institutes 
of Health allotted less than 1% of its FY2014 budget to adolescent brain research (Lee et 
al., 2014). This disparity between the economic and psychosocial burden of an early-life 
diagnosis and limited research funds restrains our ability to develop advanced tools for 
diagnosis and treatment of mental health disorders, such as SCZ. A greater appreciation 
of the adolescent critical period can expand our understanding of molecular dysfunctions 
and physiological aberrations underlying abnormal cognition and behavior in adulthood. 
NMDARs are of particular interest due to their central role in developmental 
neuroplasticity and adult cognitive functioning. Thus, we investigated the expression and 
function of NMDARs in adolescent saline and MAM animals to determine how the PFC 
may become vulnerable during postnatal development. 
 
During adolescence, MAM animals demonstrate complex changes in NMDAR 
subunit expression and synaptic physiology. As shown by Western blotting, synaptic 
NR1 protein is significantly reduced in adolescent MAM PFC, and NR2B protein levels 
are greatly decreased, although not statistically significant (p=0.056). As the constitutive 
subunit of the NMDAR complex (Paoletti et al., 2013), reduced NR1 protein levels 
indicate a decrease in post-synaptic NMDARs. Thus, we expected further investigation of 
synaptic NMDAR function on layer V pyramidal cells to be compromised following a 
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physiologically-relevant 10-pulse, 20 Hz train in layer II/III. However, we were surprised 
to find no significant differences in amplitude or charge of NMDA-eEPSCs between 
adolescent saline and MAM animals. In fact, Figure 15 shows a slight increase in 
summation in response to the initial pulses of the stimulation train in adolescent MAM 
mPFC. Additionally, PPR and stimulation intensity were not different between the two 
groups. However, our findings indicate subunit composition of NMDARs of layer V 
pyramidal cells in the adolescent MAM PFC differ from those in saline PFC. Given the 
importance of the NR2B subunit in synaptic plasticity and working memory (Wang et al., 
2013), we evaluated the contribution of NR2B subunits to NMDA-eEPSCs with a 
selective NR2B inhibitor, Ro25 (1 µM). Pyramidal cells from saline mPFC exhibited a 
45-60% reduction in NMDA-eEPSC amplitude and charge following Ro25 wash-on. 
However, Ro25 had a much stronger effect on adolescent MAM layer V pyramidal cells, 
dramatically reducing amplitude and charge of NMDA-eEPSCs by 73-87% at all pulses. 
Therefore, we postulated that adolescent MAM mPFC has a larger proportion of NR2B-
NMDARs at the post-synaptic site of layer V pyramidal neurons while saline mPFC is 
characterized by triheteromeric NR1/NR2B/NRX receptors.  
 
The extent of pharmacological inhibition by Ro25 depends on (1) the number of 
NR2B subunits contained within the NMDAR complex, as well as (2) the activity level 
of NMDARs. First, diheteromeric receptors containing the constitutive NR1 subunit as 
well as one other subunit (i.e. NR2B) will exhibit far greater reductions in NMDAR 
current than triheteromeric receptor complexes (NR1/NR2A/NR2B-containing) due to 
the increased number of Ro25 binding sites on the N-terminal domain (Hatton and 
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Paoletti, 2005). Therefore, the larger inhibitory effect of Ro25 on layer V pyramidal cells 
in adolescent MAM mPFC indicates predominantly NR2B-containing diheteromeric 
complexes are present at the post-synaptic membrane. Conversely, the moderate blockade 
of NMDA-eEPSCs by Ro25 in saline cells suggests mixed NR2B-containing 
triheteromeric complexes are more abundant during normal adolescent development. 
Alternatively, the magnitude of NMDAR activation positively correlates with the degree 
of pharmacological inhibition by Ro25 (Kew et al., 1996; Zhang et al., 2000). Due to the 
diheteromeric composition of NR2B-NMDARs in MAM mPFC, these receptors exhibit 
longer decay kinetics (Paoletti et al., 2013; Flores-Barrera et al., 2014). Therefore, the 
greater degree of receptor activation due to prolonged open channel time can further 
explain the much stronger inhibitory effect of Ro25 on NMDARs in MAM compared to 
saline animals. 
 
Our findings indicate diheteromeric NR2B-NMDARs predominate in the MAM 
mPFC whereas triheteromeric NR1/NR2A/NR2B-NMDARs are prevalent in the mPFC 
of adolescent saline animals. Although this seems antithetical to previous reports linking 
persistent NR2B expression to working memory function (Wang et al., 2008; Wang et al., 
2013), we hypothesize the incorporation of NR2A subunits serves to modulate Ca2+ 
influx to prevent excitotoxicity in the adult brain (Monaco et al., 2015), while the 
retention of NR2B subunits in the MAM PFC is a compensatory mechanism to prolong 
neuroplasticity. Our previous work in juvenile saline and MAM PFC (Chapter 3) shows 
NMDARs are significantly decreased in MAM layer V pyramidal cells. The substantial 
loss of NMDA-eEPSC amplitude and charge in layer V pyramidal cells from MAM 
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mPFC occluded the inhibition by Ro25 indicating NR2B-NMDARs are specifically 
downregulated during juvenile development. Thus, we hypothesize the retention of 
diheteromeric NR2B-NMDARs in adolescent MAM mPFC serves to extend the window 
of neuroplasticity in an attempt to compensate for the earlier loss of NR2B-NMDARs in 
juveniles. Visual processing, somatosensation, and motor functions rely on experience-
dependent synaptic plasticity as a platform for maturation (Dumas, 2005; Monaco et al., 
2015). In the corresponding cortices, NR2B-NMDARs are highly expressed during this 
critical learning phase until the NR2B-to-NR2A subunit switch occurs, which closes the 
critical period and limits further neuroplasticity. In the PFC, this subunit switch is absent 
leading to persistent expression of NR2B (Wang et al., 2008; Flores-Barrera et al., 2014), 
promoting the functional maturation of layer V pyramidal neurons and PFC-dependent 
cognitive functions. Therefore, the reduction in synaptic NR2B-NMDARs in juvenile 
MAM mPFC dampens plasticity, limiting synaptogenesis and synaptic strengthening 
(Davies et al., 1998; Konradi and Heckers, 2003). We propose the retention of NR2B-
NMDARs in adolescent MAM mPFC serves to extend the juvenile critical window in an 
attempt to lengthen the period of functional plasticity. However, compared to layer V 
pyramidal neurons in saline mPFC, the high number of NR2B-NMDARs exposes the 
adolescent brain to excitotoxicity due to excessive Ca2+ influx and may lead to pruning of 
damaged or weakened synapses (Iafrati et al., 2014). Globally, an elevation of NR2B 
subunit levels can sensitize the brain to hyperexcitability (Jantzie et al., 2015). During 
early postnatal development, stimulation of glutamate receptors with seizure-inducing 
doses of NMDA, a time during which NR2B is highly expressed throughout the 
forebrain, results in cognitive impairment in adulthood (Stafstrom and Sasaki-Adams, 
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2003). This evidence further confirmed that over-stimulation of NR2B-NMDARs in early 
postnatal development can result in cognitive impairments, likely due to an 
overabundance of intracellular calcium signaling. In this way, the NR2B subunit exposes 
the brain’s vulnerability and sensitivity to environmental perturbations during early 
postnatal development that can have direct effects on cognition in adulthood. Indeed, 
adult MAM animals demonstrate significant reductions in spine density in the mPFC 
compared to saline animals (Xing et al., 2016).  
 
Thus, we propose that a threshold of NR2B expression exists (Figure 19). In this 
case, age seems to set this threshold. In early development, bidirectional changes in 
NR2B levels can result in lasting impairment of cognitive performance and synaptic 
plasticity. When this same aberrant increase in NR2B is placed in the context of the adult 
brain, we see many pro-cognitive effects of its overexpression (Tang et al., 1999; Cui et 
al., 2011). This is intimately tied to the conductance of calcium ions through NMDARs. 
High calcium in early development results in excitotoxic events, whereas in adulthood, 
high calcium seems to restore the plasticity of the brain. How can this be? NR2B levels 
are relatively high in the PFC throughout development, suggesting a greater calcium 
influx is an integral part of PFC maturation and cognitive functioning. Thus, other critical 
developmental milestones, such as synaptic pruning and maturation of neuromodulator 
systems, contribute to prefrontal development and eventually working memory and 
cognitive functioning. 
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Our findings that post-synaptic AMPAR function is not affected in juvenile 
(Chapter 3) or adolescent MAM mPFC suggests this ionotropic glutamate receptor 
subtype is functionally intact. However, we did find a significant increase in the PPR of 
AMPA-eEPSCs, suggesting a facilitation of pre-synaptic release probability. This may be 
further evidence of compensation by the pre-synaptic machinery to facilitate 
depolarization of the post-synaptic membrane. To confirm this possibility, we will 
characterize AMPAR subunit expression, as well as levels of pre-synaptic vesicle 
packaging and release proteins to evaluate whether pre-synaptic mechanisms are also 
dysregulated in adolescent MAM PFC. 
 
Lastly, we evaluated the global levels of histone modifications, which are 
involved in learning and memory processes, in the adolescent PFC of saline and MAM 
animals. We found no significant differences in any of the modifications assayed. 
However, these Western blot findings do not preclude a role for epigenetic mechanisms 
in regulating NMDAR subunit expression and composition. Chromatin 
immunoprecipitation is a very sensitive technique for evaluating the enrichment of 
proteins at the promoter region of interest, and would be better suited for evaluating the 
levels of epigenetic repressor and facilitator proteins at NMDAR subunit genes. Further 
experiments will allow us to explore this possibility. 
  
Adolescence represents a critical developmental window during which the PFC 
undergoes the final stages of maturation, including excitatory and inhibitory circuitry 
strengthening, synaptic pruning, and dopaminergic innervation (Arnsten and Jin, 2014). 
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Insults during earlier periods of postnatal development increase the vulnerability of the 
PFC to dysfunction as it continues to mature, eventually resulting in cognitive 
impairments. In SCZ, these deficiencies in cognition are evident during the juvenile and 
adolescent periods, leading to the hypothesis that SCZ is a neurodevelopmental disorder. 
The MAM model is a reliable resource for evaluating these developmental alterations as 
it recapitulates many endophenotypes relevant to SCZ in adulthood. Thus, the findings 
herein lend insight into the neurobiology underlying cognitive delays exhibited by 
individuals prior to a diagnosis of SCZ, and contribute to the investigation of potential 
therapeutic targets during neurodevelopmental vulnerability to this debilitating disorder. 
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Figure 19 
 
Schematic representation of the effects of optimal and imbalanced NR2B/NR2A 
ratio on cell health and cognitive functions.   
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CHAPTER 5: NMDAR HYPOFUNCTION IN JUVENILE PFC IN HDISC1-
EXPRESSING MICE 
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Abstract 
 
The Disrupted in Schizophrenia 1 (DISC1) gene was originally discovered in a 
Scottish pedigree in which family members with this genetic perturbation demonstrate 
high co-segregation with mental illnesses, primarily schizophrenia (SCZ). The DISC1 
interactome is vast, and many protein partners are vital for neural development and adult 
synaptic physiology. Though the function of DISC1 is still under investigation, its 
implications in the earliest stages of brain development and adult-stage cognitive 
functions is clear. Perturbations of this protein in either developmental stage results in 
brain morphology abnormalities and cognitive impairments, respectively. However, the 
effect of dysfunctional DISC1 on early postnatal development and synaptic function has 
not yet been elucidated. This time point is of particular interest in elucidating the 
mechanisms at play in SCZ due to evidence of cognitive impairments in early 
development, prior to the typical age of onset in late adolescence or early adulthood. 
Previously, we have described impairment of N-methyl-D-aspartate receptor (NMDAR) 
synaptic physiology in the prefrontal cortex (PFC) in a neurodevelopmental model for 
SCZ. Thus, in addition to NMDAR hypofunction in the chronic stage of SCZ, 
dysfunction of this critical synaptic player begins as early as juvenile development of the 
PFC. Therefore, we investigated the consequences of the truncated human DISC1 protein 
on synaptic NMDAR expression and function in the juvenile PFC. Our results confirm 
NMDAR hypofunction is a feature of juvenile development in the PFC in this model for 
SCZ as well.  
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Introduction 
 
Originally discovered and studied in a Scottish pedigree in the 1960s and 1970s 
(Blackwood et al., 2001), the Disrupted in Schizophrenia 1 (DISC1) gene is the result of a 
balanced chromosomal translocation between non-homologous chromosomes 1 and 11 
(Millar et al., 2000). Importantly, family members with this genetic perturbation 
demonstrate high co-segregation of mental illnesses, primarily schizophrenia (SCZ), 
bipolar disorder, and depression (Millar et al., 2000; Brandon and Sawa, 2011). However, 
in genome-wide association studies (GWASs), DISC1 failed to produce any significant 
associations with SCZ (Mathieson et al., 2012). Nevertheless, the DISC1 interactome 
includes proteins that are critical mediators of neural development, migration, synaptic 
formation and maintenance (Brandon and Sawa, 2011). Therefore, genetic perturbation of 
DISC1 at these critical junctions sensitizes the brain to genetic or environmental insults, 
which contribute to the etiology of neurodevelopmental disorders (Brandon and Sawa, 
2011). SCZ is characterized as a neurodevelopmental disorder due to early 
neuroanatomical and behavioral abnormalities evident in patients (Jones et al., 1994; 
Cannon et al., 2000; Rosso et al., 2000; Chung et al., 2017). Thus, DISC1 is well-
positioned to play a role in early postnatal development, contributing to cognitive and 
behavioral deficiencies that persist into adulthood.  
 
Although the function of DISC1 is unclear, various Disc1 perturbations in animal 
models consistently recapitulate endophenotypes of SCZ, including dysfunction of PFC-
dependent cognitive functions (Clapcote et al., 2007; Hikida et al., 2007; Li et al., 2007; 
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Pletnikov et al., 2008), enlarged lateral ventricles (Pletnikov et al., 2008), reduced 
parvalbumin immunoreactivity (Abazyan et al., 2010), and dopaminergic dysfunction 
(Niwa et al., 2010). Of particular interest, N-methyl-D-aspartate receptors (NMDARs) 
are implicated in the cognitive impairments characteristic of SCZ pathology (Gilmour et 
al., 2012; Snyder and Gao, 2013), and play a critical role in neuroplasticity and functional 
development (Dumas, 2005; Yashiro and Philpot, 2008). Interestingly, DISC1 and 
NMDARs reciprocally regulate each other and synaptic physiology (Ayhan et al., 2011; 
Namba et al., 2011; Ramsey et al., 2011; Wei et al., 2014). RNAi-mediated knockdown 
of DISC1 results in enhanced NMDA currents in cortical cultures and prefrontal 
pyramidal neurons (Wei et al., 2014) as well as in hippocampus (Wang and Zhu, 2014), 
and a dominant negative construct of DISC1 leads to working memory impairments (Li 
et al., 2007). Conversely, chronic NMDAR antagonism during embryonic development 
of the dentate gyrus (Namba et al., 2011) and in the adult striatum (Ramsey et al., 2011) 
results in diminished DISC1 function. These findings implicate DISC1 in the earliest 
stages of neuronal development and in the mature brain. However, it is yet unknown the 
effects of mutant DISC1 on early postnatal development.  
 
Insufficient attention is paid to the developing brain and factors which may lead 
to dysfunction in later life (Lee et al., 2014); therefore, our goal in this study is to reveal 
the effect of truncated mutant DISC1 on NMDAR expression and synaptic physiology in 
juvenile prefrontal development. Specifically, the transgenic mouse line used herein 
results in constitutive expression of the same truncated mutant DISC1 reported in the 
Swedish cohort (Millar et al., 2000) restricted to glutamatergic neurons of the forebrain 
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(Pletnikov et al., 2008). This particular model is proposed to result in a dominant 
negative effect; endogenous DISC1 protein is significantly diminished in perinatal 
development (Ayhan et al., 2011), but not in juvenile or adult stages (Pletnikov et al., 
2008). Our findings indicate pre-synaptic release mechanisms, NMDAR and AMPAR 
function are compromised in juvenile hDISC1 PFC. 
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Methods 
 
Animals 
 
All animal procedures were performed in accordance with the National Institutes 
of Health Guide for the Care and Use of Laboratory Animals and were approved by the 
Drexel University College of Medicine Animal Care and Use Committee. Food and water 
were provided ad libitum throughout the experiments. 
 
Inducible human DISC1 (hDISC1) mutant mouse model 
 
 Homozygous mice expressing the truncated human Disrupted-in-Schizophrenia-1 
gene (hDISC1, line 1001, C57BL6/J strain) were generously donated by Dr. Mikhail 
Pletnikov (Johns Hopkins University, Baltimore, MD) (Pletnikov et al., 2008; Abazyan et 
al., 2010). B6;CBA-Tg(Camk2a-tTA)1Mmay/J (Camk2a-tTA) hemizygous mice were 
purchased from The Jackson Laboratory (stock no. 003010, Bar Harbor, ME). Expression 
of Camk2a results in expression of the tetracycline-transactivor, tTA. In the hDISC1 line, 
a tetracycline-response element (TRE) site to which tTA will bind is positioned upstream 
of the transgene. Therefore, successful breeding of Camk2a-tTA hemizygotes and 
hDISC1 homozygotes yields two types of transgenic mice: 1) experimental mice with 
both Camk2a-tTA and hDISC1 genes will yield expression of the hDISC1 transgene, and 
2) control animals wherein the tTA element is not present prohibiting the expression of 
the hDISC1 transgene. This is a TET-off system, where presentation of doxycycline 
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binds tTA and prohibits expression of hDISC1. In our experiments, hDISC1 gene 
expression is uninterrupted as our animals are never exposed to doxycycline. Further, 
because hDISC1 gene expression relies on the expression of tTA driven by Camk2a, 
forebrain- and neuron-specific expression of the mutant protein is possible.  
 
To obtain control and experimental littermates, homozygous DISC1 mice were 
paired with hemizygous Camk2a-tTA mice (Figure 20). Breeding strategies included 
pairs and trios to maximize breeding efficiency. In trio scenarios, pair-housed females 
ensured successful care for all pups. Pups were usually born at E21/P0 and weaned 
between P21 to P28, at which time offspring were group-housed according to gender and 
not genotype. Tissue from both male and female mice was collected, but only male tissue 
was used for the experiments described below.  
 
At P14, tail tip collection for genotyping and ear punch identification was carried 
out. Pups were briefly anaesthetized with isoflurane. While anesthetized, a small section 
of tail tip was cut using a clean razor blade and a small hole was punched in the ear based 
on a predetermined identification scheme. Pups were placed back with the dam and no 
further procedures were carried out until weaning or use for experiments. Pups aged P17-
P23 were classified as juveniles, P32-P39 were classified as adolescents, and P60 or older 
were classified as adults.  
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Figure 20 
X
DISC1homo Camk2a
tTA/+
Camk2atTA/hDISC1+ Camk2a+/hDISC1-
 
Schematic representation of the hDISC1 breeding strategy. Left, homozygous DISC1 
mice were paired or trio-housed with Camk2a-tTA hemizygotes. Offspring were typically 
born at E23/P0. At P14, tail tips were collected and mice received ear-punch 
identifications. Right, genotyping was performed using primers for the tTA transgene 
sequence (Jackson Laboratory). Animals were classified as mutants (green mouse) if a 
band appeared at 500 base pairs whereas control littermates (grey mouse) were identified 
by the absence of this band. NC, negative control 
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Tissue collection and western blot for synaptosomal proteins  
 
PFC tissue was collected and processed as described in Chapter 3. Briefly, 
animals were perfused with 60 mL HEPES-buffered sucrose (in mM: 320 sucrose, 4 
HEPES-NaOH buffer, pH 7.4, 2 EGTA, 1 sodium orthovanadate, 0.1 
phenylmethylsulfonyl fluoride, 10 sodium fluoride, and 10 sodium pyrophosphate). The 
brain region containing the PFC was dissected and homogenized in sucrose buffer. The 
homogenate was centrifuged at 1000 g for 10 minutes at 4°C to remove large cell 
fragments and nuclear materials. The resulting supernatant was centrifuged at 15,000 g 
for 15 minutes at 4°C to yield cytoplasmic proteins in the supernatant. The pellet from 
this spin was re-suspended in homogenization buffer and centrifuged at 15,000 g for an 
additional 15 minutes to yield washed synaptosomes. The synaptosomal fraction then was 
hypo-osmotically lysed in 9 volumes of ddH2O containing protease and phosphatase 
inhibitors and 4 mM HEPES-NaOH buffer, pH 7.4 and centrifuged at 25,000 g for 30 
minutes to yield synaptosomal plasma membranes in the pellet.  
 
A bicinchoninic acid (BCA) protein assay was performed to determine protein 
concentration. The protein sample was mixed with Laemmli sample buffer, boiled for 5 
minutes, and separated on a 7.5% SDS-PAGE gel. After electrophoresis, proteins were 
transferred to pore size 0.45 μm polyvinylidene difluoride membranes (PVDF, EMD-
Millipore, Billerica, MA). The membrane was blocked in 5% nonfat milk and probed 
with primary anti-serum. Each blot was probed for anti-mouse NR1 (Invitrogen, 32-5000, 
1:5000, Carlsbad, CA), anti-rabbit NR2A (EMD-Millipore, 04-901, 1:4000), anti-mouse 
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NR2B (EMD-Millipore, 05-920, 1:2000), anti-rabbit NR3A (EMD-Millipore, 07-356, 
1:4000), anti-rabbit NR3B (Tocris, 2060, 1:4000, Bristol, UK), and anti-mouse actin 
(Sigma, A5316, 1:100,000, St Louis, MO), which was used as a loading control. The 
blots were incubated with horseradish peroxidase-coupled anti-rabbit or anti-mouse IgG 
secondary antibody (1:5000, Vector Laboratories, Burlingame, CA), and proteins were 
visualized using enhanced chemiluminescence (ECL Plus, Amersham Biosciences, Little 
Chalfont, UK). Protein expression of each subunit was evaluated by densitometry using 
ImageJ software (NIH, Bethesda, MD). Samples from each animal were run at least 4 
times to minimize interblot variance. Raw values for NMDAR subunit proteins were 
normalized to actin and this ratio was further normalized to the first usable band on each 
membrane. These normalized values were averaged per animal to yield the final values 
which comprised the mean and standard error per group.  
 
Whole-cell patch-clamp electrophysiology 
 
Animals were anesthetized with Euthasol (0.2 ml kg−1, IP) until unresponsive to 
toe pinch, the brains were dissected, and 300 μm coronal slices containing the prelimbic 
PFC were cut into an ice-cold bath of oxygenated artificial cerebrospinal fluid (aCSF, in 
mM: 124 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2, 1 MgSO4, and 10 
dextrose, pH 7.4) using a VT-1200S vibratome tissue slicer (Leica Microsystems, 
Wetzlar, Germany). To preserve tissue quality in adolescent animals, rats were perfused 
with ice-cold sucrose solution (in mM: 87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 75 
sucrose, 25 glucose, 0.5 CaCl2, 7.0 MgSO4, pH 7.4). Slices were transferred to a holding 
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chamber, submerged in oxygenated (95% O2, 5% CO2) aCSF at 35oC, for one hour and 
then remained at room temperature until used for recording. Slices were placed into a 
recording chamber mounted on an Olympus upright microscope (BX51, Olympus 
America, Center Valley, PA), where they were continuously bathed in oxygenated aCSF 
and maintained at 36 oC. Neurons were visualized with infrared differential interference 
video microscopy. All experiments were conducted with an Axon MultiClamp 700B 
amplifier (Molecular Devices, Sunnyvale, CA), and data were acquired using pCLAMP 
9.2 software and analyzed using Clampfit 10.2 software (Molecular Devices).  
 
Spontaneous and miniature excitatory post-synaptic currents 
 
To record spontaneous or miniature excitatory post-synaptic currents (EPSCs), 
somatic whole-cell voltage-clamp recordings were obtained from layer V pyramidal cells 
using patch electrodes with an open tip resistance of 8-11 M (CsCl2 intracellular 
solution, in mM: 110 D-gluconic acid, 110 CsOH, 10 CsCl2, 1 EGTA, 1 CaCl2, 5 QX-
314, 1 ATP-Mg, 10 HEPES, at pH 7.3, adjusted with CsOH). Resting membrane 
potential was observed in current clamp mode for 1 to 2 minutes to confirm cell health. In 
voltage clamp mode, the membrane potentials were first held at -70 mV in the presence 
of picrotoxin (50 μM) to record AMPAR-mediated spontaneous EPSCs (AMPA-
sEPSCs), which are a result of both action potential-mediated and stochastic release of 
glutamate, in the absence of GABAAR-mediated neurotransmission. After 5 minutes of 
recording, tetrodotoxin (TTX, 0.5 μM) was added to the wash-on buffer to isolate 
miniature EPSCs (AMPA-mEPSCs). TTX blocks Na2+ channels, thus prohibiting action 
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potential-stimulated release of neurotransmitter. mEPSCs were recorded for at least 5 
minutes and then DNQX (20 μM) was washed on to block AMPARs. When all currents 
ceased, the membrane potential was slowly ramped up to 60 mV. NMDAR-mediated 
mEPSCs (NMDA-mEPSCs) were then recorded for at least 5 minutes.  
 
A typical s/mEPSC event was selected to create a sample template for event 
detections within a 5 minute period for each data file. The frequency (number of events) 
and amplitude of the individual events were examined with the threshold set at the 
medium level (i.e., 5 within a range of 1 to 9) in Clampfit. The detected events were then 
visually inspected to ensure specificity. 
 
Evoked excitatory post-synaptic currents 
 
To record evoked EPSCs (eEPSCs), a bipolar stimulating electrode was placed in 
layer II/III of the mPFC approximately 200-300 μm from visually-identified layer V 
pyramidal cells. Picrotoxin (50 µM) was used to block GABAAR-mediated 
neurotransmission, and DNQX (20 µM) to block AMPAR-mediated currents when 
recording NMDA-eEPSCs. Cells were held at -70 mV to record AMPA-eEPSCs, and 60 
mV to record NMDA-eEPSCs, which were evoked through the stimulating electrode 
using a paired pulse protocol at 50 Hz, and a single pulse, each with a 0.1 Hz stimulating 
interval. Stimulus intensity was adjusted until 50-100 pA eEPSC amplitude responses 
were achieved. Cells with an unstable baseline or unusual response patterns throughout 
recording were removed from the analysis. The EPSC recordings were monitored 
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throughout each experiment by implementing a -100 pA current pulse with a 200 ms 
duration, and all cells with >20% change in series resistance during recording were 
discarded. Traces were analyzed for amplitude (pA) relative to the first post-stimulus 
baseline and cumulative charge (charge transfer, nA*ms), as well as paired-pulse ratio 
(PPR). Single-pulse recordings were additionally analyzed for decay tau (ms) to compare 
channel kinetics between groups.  
 
Tissue collection and western blot for histone proteins 
 
PFC tissue was dissected as described above. The Epiquik Total Histone 
Extraction Kit (OP-0006, Epigentek, Farmingdale, NY) was used to isolate the histone 
fraction. Tissue was cut using a fresh razor blade and homogenized in Pre-Lysis Buffer. 
Homogenate was centrifuged at 10,000 rpm for 1 minute at 4°C. The pellet was 
resuspended in 3 volumes of Lysis Buffer and incubated for 30 minutes before another 
centrifugation at 12,000 rpm for 5 minutes at 4°C. The supernatant was mixed with 
Balance-DTT Buffer to yield the final histone fraction. A BCA assay was used to 
determine protein concentration. After boiling in Laemmli buffer for 5 minutes, 15 μg of 
protein were loaded on a 15% SDS-PAGE gel. After electrophoresis, blots were 
transferred to pore size 0.20 μm PVDF membrane (EMD-Millipore). Membranes were 
blocked with 5% nonfat milk and separately probed with the following primary 
antibodies: H3K9ac (Abcam, ab10812, 1:1000, Cambridge, UK), H3K18ac (Abcam, 
ab1191, 1:2000), H3K27ac (Abcam, ab4729, 1:2000), H3K27me3 (Abcam, ab6002, 
1:1000), and total histone H3 (Novus, 1:100,000, St. Louis, MO) was used as a loading 
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control. Blots were incubated with horseradish peroxidase-coupled anti-rabbit or anti-
mouse IgG secondary antibody (1:5000, Vector Laboratories), and proteins were 
visualized using enhanced chemiluminescence (ECL Plus, Amersham Biosciences). 
Protein expression for each histone modification was evaluated by densitometry using 
ImageJ software (NIH, Bethesda, MD). Samples from each animal were run at least 4 
times to minimize interblot variance. Raw values for each histone modification were 
normalized to H3 and this ratio was further normalized to the first usable band on each 
membrane. These normalized values were averaged per animal to yield the final values 
which comprised the mean and standard error per group. 
 
Data Analysis 
 
Statistical analyses were carried out using SPSS Statistics version 24.0 (IBM, 
Armonk, NY). Normality and homogeneity of variance testing determined the use of 
parametric or non-parametric tests for each dataset. Protein expression analyses, AMPA- 
and NMDA-s/mEPSC amplitude and frequency, and outcome measures from evoked 
recordings were compared using unpaired Student’s t-test or Mann-Whitney U tests. All 
data are presented as mean  standard error (S.E.). Single, double, and triple asterisks 
represent p<0.05, p<0.01, and p<0.001, respectively. 
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Results 
 
hDISC1 mutants exhibit reduced synaptic NR2A protein levels in juvenile PFC 
 
 To characterize synaptic NMDAR subunit expression, we isolated synaptosomes 
from PFC of juvenile control and hDISC1 littermates to probe protein expression using 
antibodies for NR1, NR2A, NR2B, and NR3A. Actin served as the loading control. We 
found a significant decrease in synaptic NR2A protein in hDISC1 mutants compared to 
controls (Figure 21; NR2A: control 0.92±0.04, n=6 mice, hDISC1 0.60±0.10, n=5 mice; 
t(9)=3.18, p=0.011). We found no significant differences in other synaptic NMDAR 
proteins NR1, NR2B, or NR3A (NR1: control 1.02±0.07, hDISC1 1.01±0.10; t(9)=0.09, 
p=0.932; NR2B: control 1.03±0.02, hDISC1 0.94±0.14; t(3.17)=0.71, p=0.571; NR3A: 
control 1.12±0.14, hDISC1 0.82±0.80; t(9)=1.75, p=0.115).  
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Figure 21 
 
Synaptic NR2A protein is significantly diminished in synaptosomes of juvenile 
hDISC1 PFC compared to control PFC. Synaptosomes isolated from juvenile control 
and hDISC1 PFC demonstrated reduced synaptic NR2A protein (NR2A: control 
0.92±0.04, n=6 mice, hDISC1 0.60±0.10, n=5 mice; p=0.011). We found no significant 
differences in other synaptic NMDAR proteins (NR1 p=0.932; NR2B p=0.571; NR3A 
p=0.115).  
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Evoked AMPA-EPSCs in juvenile hDISC1 pyramidal cells are significantly increased 
compared to control cells 
 
 To directly investigate pre-synaptic release probability as well as post-synaptic 
AMPAR function, we recorded layer V pyramidal neurons while activating layer II/III 
afferents in the PFC using a paired-pulse 20 Hz stimulation paradigm. Picrotoxin (50 
µM) was bath-applied to block GABAAR-mediated neurotransmission as the cell was 
held at -70 mV. Amplitude, paired-pulse ratio (PPR), and stimulation intensity were 
compared between juvenile control and hDISC1 cells. With no significant difference in 
stimulation intensity (control 88.68±15.36, n=8 cells, hDISC1 93.87±16.07, n=9 cells; 
t(15)=-0.23, p=0.820), the amplitude of AMPA-eEPSCs was significantly increased in 
hDISC1 layer V pyramidal cells compared to controls (Figure 22; control 32.06±5.39, 
hDISC1 45.53±7.49; U=15, p=0.046). Pre-synaptic release probability was increased, 
although not significantly, in the mutants as well (PPR: control 1.32±0.13, hDISC1 
1.78±0.30; t(10.68)=-1.40, p=0.189).  
 
NMDARs in juvenile hDISC1 mPFC exhibit faster decay kinetics 
 
 To further explore the function of post-synaptic NMDARs, we recorded evoked 
EPSCs as describe for AMPA-eEPSCs with two notable exceptions. Membrane potential 
was held at 60 mV to account for spatial clamp issues, and DNQX (20 µM) was used in 
addition to picrotoxin to inhibit both GABAAR- and AMPAR neurotransmission. We first 
recorded responses elicited by the paired-pulse stimulation paradigm, and then switched 
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to a single-pulse paradigm to evaluate decay properties of post-synaptic NMDARs. 
Again, we found no differences in the stimulation intensity required to elicit NMDA-
eEPSCs (control 78.56±14.59, n=8 cells, hDISC1 90.65±19.29, n=8 cells; t(14)=-0.50, 
p=0.625). In addition, an observed reduction in amplitude of NMDA-eEPSCs from 
hDISC1 cells did not reach significance (Figure 23; control 50.74±8.84, hDISC1 
33.10±5.62; t(14)=1.68, p=0.114). Surprisingly, we revealed a significant increase in PPR 
in mutant animals compared to controls (Figure 23; control 0.69±0.07, hDISC1 
0.88±0.05; t(14)=-2.31, p=0.037). Further, single-pulse stimulation elicited NMDA-
eEPSCs with faster decay kinetics in juvenile hDISC1 mutant mice compared to control 
littermates (Figure 24; control 134.21±13.99, hDISC1 94.76±9.73; t(14)=2.32, p=0.036).  
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Figure 22 
 
Synaptic AMPAR function is increased in hDISC1 mutant animals compared to 
control littermates. (A) Representative traces and (B) summary scatterplots from control 
littermates and hDISC1 mutants demonstrate a significant increase in amplitude of 
AMPA-eEPSCs without a significant difference in stimulation intensity (control 
32.06±5.39, hDISC1 45.53±7.49; p=0.046). Pre-synaptic release probability was 
increased, although not significantly, in the hDISC1 mutants (control 1.32±0.13, hDISC1 
1.78±0.30; p=0.189). 
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Figure 23 
 
Enhanced pre-synaptic release in juvenile mPFC of hDISC1 mutants. (A) 
Representative traces, we observed a reduction in amplitude of NMDA-eEPSCs from 
hDISC1 cells, which did not reach significance (control 50.74±8.84, hDISC1 33.10±5.62; 
p=0.114). (B) We also revealed a significant increase in PPR in mutant animals compared 
to controls (control 0.69±0.07, hDISC1 0.88±0.05; p=0.037).  
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Figure 24 
 
Synaptic NMDA currents display faster decay kinetics in juvenile mPFC compared 
to control littermates. Left, representative traces and right, summary scatterplot 
demonstrating a single-pulse stimulation paradigm elicited NMDA-eEPSCs with faster 
decay kinetics in juvenile hDISC1 mutant mice compared to control littermates (control 
134.21±13.99, hDISC1 94.76±9.73; p=0.036). 
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Discussion 
 
 Numerous constructs of mutated DISC1 exhibit behavioral and structural features 
characteristic of SCZ (Cash-Padgett and Jaaro-Peled, 2013). However, many of these 
silencing tools have been used in vitro or in the adult brain. The neurodevelopmental 
nature of SCZ begs the question, what are the effects of the truncated hDISC1 construct 
on early postnatal brain development? The cognitive impairments observed in individuals 
who are later diagnosed with SCZ indicate postnatal development is of particular 
relevance to the neurobiological underpinnings of early dysfunctions (Cannon et al., 
2000; Rosso et al., 2000; Chung et al., 2017). Our work is the first to demonstrate the 
relevance of the NMDAR system in early postnatal development of the PFC in this 
hDISC1 model. We found significant effects of hDISC1 on levels of the synaptic NR2A 
subunit, and synaptic physiology of both NMDARs and AMPARs. Our findings suggest 
alterations to glutamatergic neurotransmission during juvenile development may sensitize 
the PFC to cognitive deficits later in life (Hikida et al., 2007; Li et al., 2007; Pletnikov et 
al., 2008; Abazyan et al., 2010).  
 
 In hDISC1 mutant mice, we found synaptic NR2A subunit protein is significantly 
reduced in the juvenile PFC compared to control animals. Somatic recordings of NMDA-
eEPSCs from layer V pyramidal neurons during stimulation of layer II/III afferents 
revealed a significant increase in PPR, a measure of pre-synaptic release probability, as 
well as a non-significant reduction in amplitude. Reductions in NR2A protein and 
NMDA-eEPSC amplitude support our hypothesis that NMDAR hypofunction is evident 
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in the developing PFC of this model for SCZ. The NR2A subunit plays an important role 
in synaptic plasticity during development; typically NR2B-NMDARs are highly 
expressed during early stages of development, followed by a switch from primarily 
NR2B- to NR2A-containing receptors, signifying functional maturation of those regions 
(Sheng et al., 1994; Dumas, 2005; Zhao et al., 2005; Yashiro and Philpot, 2008; Monaco 
et al., 2015). In contrast, the PFC persistently expresses NR2B throughout development 
and adulthood (Wang et al., 2008; Monaco et al., 2015); thus, a shift in NR2B/NR2A 
ratio during the juvenile critical developmental period can have significant effects on 
cognitive capacities (Snyder et al., 2013; Xing et al., 2016; Li et al., 2017). Indeed, 
deletion of the NR2A subunit during development reduces the threshold for long-term 
potentiation (LTP) and depression (LTD), compromising metaplasticity in the visual 
cortex (Philpot et al., 2007). Conversely, dysregulated elevation of NR2B levels during 
juvenile development impairs LTP induction and maintenance (Iafrati et al., 2014) and 
maturation of GABAergic interneurons in the PFC (Bouamrane et al., 2016). In addition, 
a reduction, although non-significant, in NMDA-eEPSC amplitude in these mutant mice 
carries biological implications for the improper development of the PFC. Indeed, these 
findings may underlie the cognitive and synaptic dysfunction reported in adult hDISC1 
mice (Li et al., 2007; Pletnikov et al., 2008; Abazyan et al., 2010; Ayhan et al., 2011; 
Holley et al., 2013).  
 
Surprisingly, we also observed a significant speeding of decay kinetics of 
NMDA-EPSCs. Given the decrease in NR2A and purported increase in NR2B subunits, 
we expect decay to be significant slowed in these receptor complexes (Fu et al., 2005; 
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Gray et al., 2011). Indeed, Wei et al. (2014) demonstrated increased NMDA-eEPSC 
decay in addition to increased NR2A protein levels and enhanced NMDA-EPSC 
amplitude in cortical cultures treated with DISC1 shRNA (Wei et al., 2014). However, 
comparing these data directly to our own is difficulty given the disparities in 
experimental design between these works: our transgenic model constitutively expresses 
hDISC1 protein beginning from embryonic development, whereas Wei et al. (2014) 
targeted endogenous mouse DISC1 protein using short-term shRNA knockdown. 
Conceptually, both approaches should yield the same result: hDISC1 is proposed to exert 
a dominant negative effect on endogenous DISC1 protein, resulting in diminished DISC1 
function (Li et al., 2007; Ayhan et al., 2011); however, the chronic expression of hDISC1 
allows for compensatory mechanisms to occur in the intact biological system compared 
to the rapid affects afforded by RNAi-mediated methods. Therefore, our findings in 
juvenile hDISC1 mice reflect the effect of developmental hDISC1 expression, which is 
more relevant to the human population (Millar et al., 2000; Brandon and Sawa, 2011). 
Alternatively, these changes in evoked NMDAR-mediated responses may be localized to 
different dendritic compartments of the pyramidal cell, which would not be 
distinguishable by our global assessment of NR2A protein. Kumar and Huguenard (2003) 
elegantly demonstrated that NMDARs of differential composition are distributed 
according to afferent inputs; local cortical connections are mediated by diheteromeric 
NR1/NR2B-NMDARs whereas calloso-cortical synapses contain triheteromeric 
NR1/2A/2B or NR3 subunits (Kumar and Huguenard, 2003). Thus, layer-specific 
differences in synaptic NMDAR composition may occur in developing hDISC1 PFC. 
Here, we recorded layer II/III synapses onto layer V pyramidal cells; however, layer V to 
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layer V synapses are worth exploring to compare afferent-specific effects of hDISC1 in 
juvenile PFC circuitry.  
  
 In addition to NMDAR hypofunction, juvenile hDISC1 mPFC demonstrates a 
significant increase in PPR, a measure of pre-synaptic release probability. Facilitation of 
currents in response to a train of stimuli can occur by multiple pre-synaptic mechanisms 
such as residual calcium accumulation in the pre-synaptic bouton after the first stimulus, 
saturation of calcium-binding sites on calcium-buffering proteins, and calcium-dependent 
facilitation in a use-dependent manner (Fioravante and Regehr, 2011). Indeed, facilitation 
of NMDA currents is mediated by pre-synaptic effects of hDISC1 expression on the 
probability of vesicular release (Maher and LoTurco, 2012). RNAi-mediated DISC1 
knockdown results in facilitation of post-synaptic NMDA currents whereas 
overexpression of wild-type DISC1 protein reliably results in paired pulse depression; 
thus, the role of pre-synaptic DISC1 may be to control the reliability of glutamate release 
(Maher and LoTurco, 2012). Compromising this system alters the synaptic plasticity 
dynamics in the developing PFC, upon which the proper development of cognitive 
faculties relies. However, these data are in contrast to others’ findings demonstrating 
weakened pre-synaptic architecture and impaired vesicular transport by motor proteins in 
cultured neurons (Flores et al., 2011) as well as patient-derived induced pluripotent stem 
cells (Wen et al., 2014). Further elucidation of pre-synaptic function in the context of 
developmental hDISC1 expression is warranted. 
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 PPF in layer V pyramidal neurons in hDISC1 mPFC may account for the 
augmented amplitude of AMPA-eEPSCs. NMDAR hypofunction can result in higher 
levels of synaptic AMPARs as a result of homeostatic plasticity changes (Hall et al., 
2007; Hall and Ghosh, 2008; Gray et al., 2011). Holley et al. (2013) observed significant 
increases in excitatory spontaneous AMPA-EPSCs without significant alteration of 
spontaneous inhibitory events on layer II/III pyramidal cells in PFC, suggesting 
hyperexcitability of the PFC circuitry in adult hDISC1 mice (Holley et al., 2013). Thus, 
pre-synaptic alterations in release may be augmented persistently through development 
and into adulthood, contributing to dysregulation of PFC microcircuitry, which is critical 
for PFC-dependent cognition (Goldman-Rakic, 1995; Monaco et al., 2015). Evaluation of 
synaptic AMPA-EPSCs in adolescent hDISC1 mice will yield further insights into this 
hypothesis. 
 
 The complex etiology of SCZ is a result of both genetic and environmental 
perturbations. Here, we explore the effects of the hDISC1 genetic aberration found to 
highly co-segregate with neuropsychiatric disorders, SCZ among them (Millar et al., 
2000; Blackwood et al., 2001; Brandon and Sawa, 2011). Much attention has been 
dedicated to the effects of mutated DISC1 protein on cellular dysfunction in early 
neuronal development, or synaptic physiology and cognitive dysfunction in the adult 
brain; thus, we aim to fill a gap in understanding the effects of hDISC1 on PFC 
development in juvenile animals and how this may contribute to cognitive deficits and 
SCZ phenotypes in adulthood. 
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CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS 
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 The overarching hypothesis of this thesis is NMDAR hypofunction in the PFC, a 
postulated mechanism of cognitive dysfunction in the adult SCZ brain, extends to early 
stages of postnatal development, specifically evident in juveniles and adolescents in 
animal models for SCZ. In particular, our focus was on the cellular physiology and 
mechanisms underlying this early postnatal dysfunction of the PFC, a region vital for 
cognitive faculties. Because working memory is a constituent process of higher-order 
cognition (Goldman-Rakic, 1995) and is intimately dependent on NR2B-NMDARs 
(Wang et al., 2013; Monaco et al., 2015), this work evaluates the functional consequences 
of NR2B mis-expression on the developing PFC. Supporting this hypothesis, we 
observed significant alterations in synaptic NR2B/NR2A ratios as well as deficient 
physiology of NMDA currents in layer V pyramidal neurons, the critical cell layer 
exerting top-down control by the PFC, in both the MAM and hDISC1 models for SCZ. 
Further, we explored mechanisms that may underlie this dysfunction and determined 
epigenetic hyper-repression of Grin2b contributes to reduced synaptic NR2B protein in 
juvenile MAM animals. Finally, we have identified, for the first time, a potential 
compensatory mechanism of juvenile NMDAR hypofunction in adolescent MAM PFC. 
The implications of this finding remain to be fully appreciated until further 
experimentation can provide clarification. 
 
NMDAR hypofunction in the developing PFC 
 
 NMDAR hypofunction is a proposed mechanism of SCZ, due to the emergence of 
cognitive dysfunction and other SCZ-relevant endophenotypes following 
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pharmacological NMDAR antagonism. However, less information can be gathered from 
the developing brain because SCZ is only diagnosed in late adolescence and early 
adulthood, and probing the function of the NMDAR system in humans is limited to 
imaging technology (Lee et al., 2014). Gross lesions of the developing PFC result in 
executive dysfunction and disinhibited behavioral outbursts that persist from early 
development to adulthood (Eslinger et al., 2004). These cognitive-behavioral 
abnormalities during school-age years undoubtedly impair an individual’s ability to meet 
developmental milestones. In addition to these delays, cognitive impairment reaches a 
plateau at the age of onset of SCZ (Hoff et al., 2005). Thus, before a formal diagnosis and 
treatment plan can be employed, patients are already severely affected by the 
neurophysiological deficits underlying cognitive impairments in SCZ. Again, it is 
difficult with current technology to evaluate the physiological underpinnings of these 
dysfunctions in the human brain. Therefore, we must cautiously use animal models for 
SCZ to guide our understanding of this pathology. 
  
 The NMDAR system plays a critical role in synaptic plasticity processes during 
juvenile and adolescent development that are necessary to establish proper cognition in 
adulthood. Because PFC functional maturation occurs later and longer than other brain 
regions, this region is exposed to genetic vulnerabilities and/or environmental insults well 
into adolescence (Kolb et al., 2012; Monaco et al., 2015). Furthermore, the innervation of 
the dopaminergic system occurs during this critical developmental period (Arnsten and 
Jin, 2014), and impairment of receptor signaling complexes compromise the 
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neuromodulator systems that are another critical factor of cognitive regulation in the adult 
PFC (Monaco et al., 2015).  
 
Intervention during PFC development in patients at-risk for SCZ presents a 
fundamental process that is currently untapped. As shown here, NMDAR hypofunction 
occurs during the early stages of postnatal development, and is proceeded by disruption 
of the dopaminergic system. The current FDA-approved therapeutic approach is to target 
this later dopaminergic dysfunction in an effort to minimize the symptoms and functional 
impairments characteristic of SCZ. However, therapeutic agents that have previously 
failed to demonstrate efficacy in clinical trials may be more effective when employed 
during the earlier stages of development, specifically during the window of NMDAR 
hypofunction. Indeed, treatment during juvenile development with an mGluR2 
agonist/mGluR3 antagonist has demonstrated ameliorative effects on working memory 
function and NMDAR-mediated neurotransmission (Li et al., 2017). This finding 
highlights the importance of developmental NMDAR function in the maturation of 
cognitive functions, a process which is disrupted and can be subsequently recovered in 
the MAM model for SCZ by a brief pharmacological intervention during juvenile 
development. Further, current antipsychotic medications demonstrate minimal 
therapeutic efficacy in treating cognitive deficits in SCZ, suggesting the dopaminergic 
system is not capable of repaired the pathological processes that have left lasting damage 
to the PFC.  
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To model the neurodevelopmental aspect of NMDAR hypofunction, acute 
pharmacological blockade of NMDARs with PCP during gestation was found to elicit 
SCZ-like phenotypes in adulthood (Mouri et al., 2007; Jones et al., 2011; Coyle, 2012). 
More specifically, transient NMDAR antagonism during early juvenile development in 
mice also results in SCZ-relevant phenotypes, including diminished parvalbumin 
immunoreactivity, impaired latent inhibition, and poor behavioral flexibility (Jeevakumar 
et al., 2015). Interestingly, several studies have shown treatment during the juvenile 
period for various cellular aberrations is sufficient to restore cognitive and structural 
abnormalities in adult animals (Iafrati et al., 2014; Jeevakumar et al., 2015; Xing et al., 
2016; Li et al., 2017). However, in models for SCZ where these receptors are not directly 
targeted, less evidence has been put forth regarding the state of NMDAR function during 
postnatal development. This work fills that gap; we show imbalance of the NR2B/NR2A 
ratio, via alterations in either subunit protein, is evident in juvenile MAM and hDISC1 
animals, models in which psychosis-like phenotypes and cognitive impairments are 
reported in the adult stage (Flagstad et al., 2004; Flagstad et al., 2005; Moore et al., 2006; 
Li et al., 2007; Pletnikov et al., 2008; Abazyan et al., 2010). We have also found that 
NMDAR levels are not affected in early juvenile (P14) animals, suggesting the critical 
window of juvenile development begins at the P21 time point (Xing et al., 2016).  
 
In juvenile MAM and hDISC1 animals, NMDAR hypofunction is due to an 
imbalance of NR2B/NR2A ratio, the two prominent NMDAR subtypes implicated in 
developmental processes (Paoletti et al., 2013). In MAM animals, synaptic NR2B levels 
are significantly reduced, and in hDISC1 animals, synaptic NR2A protein is significantly 
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reduced. These differential synaptic protein reductions result in diminished synaptic 
NMDA current, leading to dysfunctional glutamatergic neurotransmission at one of the 
critical periods of PFC development.  
 
Future experiments exploring the subunit composition of juvenile NMDARs in 
hDISC1 animals are necessary to confirm the reduction in synaptic NR2A. Inhibition 
with TCN-201, a selective NR2A subunit antagonist, should significantly reduce NMDA-
eEPSCs in control animals, but a substantial loss of synaptic NR2A protein in hDISC1 
PFC will occlude the pharmacological effect. Further, the increase in pre-synaptic release 
probability evident in a paired-pulse stimulation paradigm muddies the potential post-
synaptic effect on NMDARs. Bath application of NMDA would circumvent the possible 
effects of hDISC1 on the pre-synaptic vesicle machinery and allow us to explore 
NMDAR function when glutamate binding sites are saturating and presumably all 
NMDARs are activated. To explore pre-synaptic changes in hDISC1 PFC, 
immunohistochemistry using mPFC-containing slices to assess levels of vesicular 
packaging proteins and pre-synaptic markers, such as synaptophysin, will lend insight 
into the functional condition of these synaptic connections. A full functional profile of 
both pre- and post-synaptic sites is still unlikely to give us a complete picture of the 
pathophysiology underlying SCZ. Instead, it can lead us to explore mechanisms by which 
these synapses become hypofunctional and further our understanding of the highly 
complex development of a brain region as vital as the PFC.   
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Compensation for NMDAR hypofunction  
 
 By investigating NMDAR function during juvenile and then adolescent 
development, we are able to demonstrate the progressive effects of NMDAR 
hypofunction on this receptor system in the PFC. In saline-exposed PFC, we observe 
similar changes to NMDAR function when probing the subunit composition with a 
selective NR2B antagonist, Ro25. That is, Ro25 is able to inhibit NMDA-eEPSC 
amplitude and charge moderately. Further, we observed that an initial reduction in 
synaptic NR2B-NMDARs during juvenile development in the MAM PFC is followed by 
a rise in synaptic NR2B-mediated current in adolescence, as shown by the substantial 
effect of Ro25 on NMDA-eEPSC amplitude and charge. Thus, we concluded that 
synaptic NMDARs in adolescent MAM PFC are primarily diheteromeric NR2B-
NMDARs. We propose that this is an over-compensation due to the low NR2B-NMDAR 
levels in juvenile MAM PFC. In fact, increased NR2B-NMDARs in the apical dendrites 
of layer V pyramidal cells during adolescent development promotes functional 
maturation of the PFC, specifically due to increased dopamine D1 receptor tone (Li et al., 
2010) and is mediated by protein kinase A signaling (Flores-Barrera et al., 2014) and/or 
protein kinase C signaling (Li et al., 2010). Interestingly, post-mortem evaluation of PFC 
tissue from SCZ patients as well as chronic ketamine users reveals an increase in D1R 
levels (Narendran et al., 2005), supporting the possibility that NR2B-NMDARs are 
increased in the adult SCZ brain. However, the maintenance of high NR2B-NMDAR 
levels compared to normal development exposes the PFC to excitotoxicity (Monaco et 
al., 2015). NR2B subunits confer a longer open channel time than NR2A subunits, 
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resulting in higher Ca2+ influx (Paoletti et al., 2013). Thus, aberrant NR2B-NMDAR 
elevation in adolescent MAM PFC may serve a compensatory role, but also sensitize the 
still-developing PFC to excitotoxic damage (Monaco et al., 2015). Indeed, oxidative 
stress is proposed as another major hypothesis of neurodevelopmental dysfunction in 
SCZ (Do et al., 2009).  
  
Another important question to be addressed is whether these receptors are 
primarily synaptic or extrasynaptic. To test insertion dynamics of NMDARs between 
saline and MAM animals, complete blockade of all activated synaptic NMDARs by the 
activity-dependent and irreversible antagonist MK-801 (Li et al., 2010) followed by 
stimulation of D1R activity (Li et al., 2010; Flores-Barrera et al., 2014), any restored 
NMDAR-mediated activity would be due to lateral diffusion of extra-synaptic NMDARs. 
Using this approach, we can evaluate the degree of NMDAR insertion in saline compared 
to MAM animals. Further, using Ro25 to selectively block NR2B-NMDARs from this 
newly inserted pool, we can evaluate the proportion of extrasynaptic NMDARs that 
exhibit this subunit composition. Insights from this experiment will reveal the preferential 
composition of NMDARs in adolescent PFC of MAM compared to saline animals, as 
well as the readily available pool of extrasynaptic receptors in MAM animals. The 
significant reduction in synaptic NR1 protein suggests total NMDAR levels may indeed 
be diminished in adolescent MAM PFC.  
 
Furthermore, to reveal the identity of the third subunit in triheteromeric NMDARs 
in adolescent saline PFC, we will use a pharmacological approach to inhibit NR2A and 
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NR2B subunits. If NR2A subunits are indeed present in these receptors, no NMDAR-
mediated current should remain in the presence of both TCN-201 and Ro25, NR2A and 
NR2B selective blockers, respectively. Future experiments may employ electron 
microscopy, which is the best technique to confirm the composition of these receptors 
definitively.  
  
Epigenetic mechanisms in SCZ 
 
 In addition to elucidating the synaptic physiology of juvenile and adolescent PFC 
in MAM and hDISC1 animals, we explored a potential mechanism for dysregulated 
expression of NMDAR subunit protein. We were able to identify an epigenetic 
mechanism of Grin2b repression in the juvenile MAM PFC that contributes to NMDAR 
hypofunction. Epigenetic regulation of gene expression as a mechanism of dysfunction in 
neuropsychiatric disorders is receiving increasing attention (Nestler et al., 2016). These 
complex mechanisms of gene regulation provide an interesting new approach to 
understanding these illnesses because they indicate environmental insults can be 
translated into altered gene expression patterns without affecting the genetic code. We are 
far from employing therapeutic agents to successfully treat mental health disorders; 
however, they provide a relatively novel series of mechanistic insights that continues to 
be explored.   
 
 We have revealed an epigenetic mechanism that regulates Grin2b expression in 
the endogenous NR2B-to-NR2A subunit switch (Rodenas-Ruano et al., 2012; Tamminga 
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and Zukin, 2015) is aberrantly employed in the developing PFC to repress Grin2b 
expression in juvenile MAM PFC. REST (RE1-silencing transcription factor) is an 
endogenous repressor protein of Grin2b expression, with selectivity for this gene among 
the NMDAR subunits. REST enrichment at the Grin2b promoter, along with H3K27me3 
enrichment, represses Grin2b in juvenile MAM animals. This finding is of particular 
interest because others have reported altered histone modification patterns in developing 
MAM PFC (Mackowiak et al., 2014), but have not demonstrated the specificity of an 
aberrant epigenetic program for any genes, as we have here.  
 
 Nonetheless, a more thorough investigation of histone markers and repressor 
enzymes at the promoter regions of Grin1, Grin2a, and Grin2b in juvenile animals will 
allow for a better understanding of epigenetic regulation in the developing MAM PFC 
throughout development. Thus, although Western blot analysis revealed no significant 
differences between histone modifications in adolescent saline and MAM PFC, 
chromatin immunoprecipitation may reveal protein-chromatin interactions that can be 
masked by global protein assessments.  
 
Relevance of SCZ models to the human condition 
 
There is a long-standing debate about whether rats have what could be a structural 
homolog to the primate PFC (Preuss, 1995; Seamans et al., 2008). The questions still 
remain: do rats have Delay cells as have been observed and studied in the primate dlPFC, 
and how can findings in rodents be extrapolated to primates? In order to evaluate whether 
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rats have a region comparable to the primate dlPFC, a set of criteria are commonly used 
to study the homology of these species’ cortices. Focusing on (1) the pattern and relative 
density of specific connections among the PFC and other brain regions, as well as (2) the 
electrophysiological and behavioral properties that make up the functional PFC (Uylings 
et al., 2003). Firstly, based on anatomical definitions, it has been shown that both 
nonhuman primate and rat PFC receive their most dense projections from the 
mediodorsal nucleus of the thalamus (Ferguson and Gao, 2014), a major PFC identifier. 
Furthermore, both rat and primate PFC receive vast afferent projections from other 
cortical areas, primarily those of sensory and limbic origins (Van Eden et al., 1992). 
Anatomical evidence supports the notion that rat mPFC is related to primate anterior 
cingulate cortex as well as dlPFC (Seamans et al., 2008). Thus, previous literature 
suggests that rats do have an anatomical region relevant to the study of PFC-dependent 
cognitive functioning. However, it is still unclear whether rat PFC contains a discrete 
region comparable to primate dlPFC, and therefore, whether rats can provide a useful tool 
to model dorsolateral function and dysfunction, specifically (Preuss, 1995). Comparing 
the neuroanatomical correlates of behavior among species is more difficult given the 
unique survival mechanisms of each species (Uylings et al., 2003). Behavior is 
essentially the expression of an animal’s capability to respond to environmental demands 
(Uylings et al., 2003). Through this simplified definition, it becomes easier to identify the 
brain regions specifically responsible for weeding out distracting stimuli, placing 
incoming information in a previously developed context, and allowing for an appropriate 
behavioral response, be it new or old. We cannot deny that this function serves a critical 
role in the survival of both rats and nonhuman primates.  
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In primates, lesions to dlPFC result in deficits to working memory function. In 
rats, lesions to the mPFC, also result in severe working memory deficits, specifically in 
acquisition and retention of a task (Uylings et al., 2003). We can therefore expect that 
neurons with properties similar to Delay cells as described in the dlPFC may also exist in 
the rat mPFC. In fact, such cells have recently been identified in the rat mPFC via 
electrophysiological recordings made during a modified delayed alternation Y-maze task 
(Yang et al., 2014). Through this technique, Yang et al. (2014) identified a subset of 
pyramidal neurons within the mPFC that respond in a transient, but not persistent, 
manner during the delay period of this paradigm of Y-maze. Interestingly, they identified 
three types of delay-like cells: those that fire during the early, middle, or late stages of the 
delay period (Yang et al., 2014). Therefore, from an electrophysiological perspective, we 
can conclude that rats do indeed possess a cellular correlate for encoding working 
memory information. It should be noted that in the eight-arm radial maze, a more 
cognitively complex task, such delay-like cells were not identified in the rat mPFC (Jung 
et al., 1998) (Jung et al., 1998). Thus, these characteristic firing patterns in the rat mPFC 
may be dependent on the cognitive load imposed by each behavioral task. Interestingly, 
the activity of discrete cells throughout the delay stage of a working memory task has 
also been identified in primate dlPFC (Rainer et al., 1999; Funahashi and Inoue, 2000). 
Thus, there appears to be a network of cells in the rat mPFC capable of encoding working 
memory-relevant information (Yang et al., 2014), as in the primate dlPFC. However, it 
remains to be determined whether these cells express NR2B-NMDARs, and whether they 
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are similarly sensitive to NR2B antagonism during a working memory task, as those 
described in primate dlPFC. 
 
Clinical implications 
 
Operating under the hypothesis that SCZ is a disorder of synaptic dysfunction, 
one may believe a single treatment, or combination of therapeutic agents, will be able to 
completely recovery cognitive deficits in this disorder. However, we must not forget the 
overt structural damage to the SCZ brain. Decreases in grey and white matter, as 
observed by fractional anisotropy, demonstrate reductions in myelination (Green et al., 
2004). Therefore, we must consider cognitive impairments, and even positive and 
negative symptoms, can likely only recover to a certain degree, given our current 
inability to treat these structural alterations (Green et al., 2004). Nonetheless, functional 
improvement for patients will lessen the economic burden of this debilitating illness as 
well as the psychosocial burden on family and caregivers. These steps to independence 
for SCZ patients are the ultimate goal of our research endeavors.  
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